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GENETIC ASPECTS OF MIGRAINE
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Background Familial Hemiplegic Migraine (FHM), Sporadic
Hemiplegic Migraine (SHM), and Basilar-type Migraine (BM) are
phenotypically similar subtypes of migraine with aura (MA), differ-
entiated only by motor symptoms, which are not present in BM.
They are as well the only subforms of migraine where genetic
defects have been found. FHM1 and some cases of SHM are char-
acterized by mutations on the CACNA1A gene (chromosome
19p13), coding for the main subunit of the P/Q-type Ca2+ channels.
Mutations on the ATP1A2 gene (chromosome 1q23), coding for the
main subunit of the Na+/K+ pump have been found in FHM2 and in
one family affected by BM. However, some FHM patients do not
bear mutations on these genes, so that at least a third FHM locus is
expected (FHM3). One study identified an FHM locus on chromo-
some 1q31, which contains the CACNA1E gene, coding for the
main subunit of R-type Ca2+ channels, similar in function and loca-
tion to the P/Q-type. A linkage to the 1q31 locus has been suggested
also for common forms of migraine.
Methods We searched for variations in the CACNA1E gene in a large
group of migraineurs (n=111; migraine without aura (MO)=29;
migraine with typical aura (MA)=56; Basilar-type Migraine (BM)=9;
Sporadic Hemiplegic Migraine (SHM)=11; Familial Hemiplegic
Migraine-(FHM)=6; and in a control group n=104). Screening was per-
formed by direct sequencing on blood genomic DNA.
Results We identified a novel single nucleotide polymorphism
(D840E) in exon 19 of the CACNA1E gene. It was present in 14.4%
of control subjects and in 18% of migraineurs. It was significantly
more represented in FHM, SHM, and BM patients (34.6%) than in MA
patients (8.9%, p=0.01) and control subjects (p=0.03). 
Conclusions In this study we report a novel polymorphism in the
CACNA1E gene (D840E), which was particularly represented in some
subtypes of migraine with aura, such as FHM, SHM and BM. This
finding supports the hypothesis that abnormalities on locus 1q31 and
particularly on the CACNA1E gene may represent the genetic basis for
some subforms of migraine with aura and that CACNA1E is a suitable
candidate for FHM3. 
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Introduction Mutations in the CACNA1A gene on chromosome
19p13, encoding a neuronal calcium channel subunit, have been found
in patients affected by Familial (FHM1) [1] and Sporadic Hemiplegic
Migraine (SHM) [2]. Some families with FHM (FHM2) [3] and
Basilar-type Migraine (BM) [4] bear mutations on the ATP1A2 gene
(chromosome 1q23). These findings suggest that FHM, SHM and BM
are not only phenotypically similar subtypes of migraine with aura but
also allelic disorders. Sib-pair [5, 6] and linkage studies [7] suggested
that abnormalities on the CACNA1A gene may also be at the basis of
common forms of migraine such as migraine without and with typical
aura. In our study, we screened for CACNA1A gene variations in a
group of probands with FHM, SHM or BM and compared them to
migraine patients with typical aura (MA), migraine patients without
aura (MO), and control subjects.
Methods A total of 120 migraine patients (MO (n=33), MA (n=59),
FHM (n=11), SHM (n=7), BM (n=10)) and 124 control subjects were
enrolled and studied for gene screening after having obtained their
informed consent. Complete screening of the CACNA1A gene was
obtained in 3 BM patients and 1 SHM patient. Two patients with FHM
were screened for the mutations known in FHM [2]. The remaining
patients and controls were screened only for the variations found in the
above preliminary patient groups.
Results None of the known mutations were found in the studied sub-
jects. Two new single nucleotide polymorfisms, E918D and E993V,
were identified in the CACNA1A gene with similar prevalence in both
migraine patients (24.4% and 27.3%, respectively) independently of
subtype diagnosis and in controls (27.4% and 27.7%).
Conclusions CACNA1A gene mutations reported in the literature were
not confirmed in our BM, FHM and SHM patients. The variations we
described are polymorphisms, since they were highly represented in
MO and MA patients and in control subjects as well. Our findings con-
firm that CACNA1A gene variations are not present in most migraine
patients, even affected by subtypes of migraine with aura supposed to
be allelic disorders of FHM.
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Background It has been recently demonstrated that migraine is char-
acterized by subclinical brain infarctions and white matter lesions.
Several genetic risk factors have been associated with migraine, but no
study has unravelled a possible relationship between migraine and
Notch3, which is involved in vascular damage. Mutations in the
Notch3 gene have been demonstrated to be pathogenetic for Cerebral
Autosomal Dominant Arteriopathy with Subcortical Infarcts and
Leukoencephalopathy (CADASIL), a small vessel disease of the brain
characterized by migraine.
Objective The aim of the present study was to evaluate whether the
functional Notch3 polymorphism T6746C, which is not causative for
CADASIL, might be a risk factor for migraine.
Methods One hunderd and fifty-six migraine patients and 128
headache-free healthy volunteers entered the study. Demographic and
clinical characteristics were carefully recorded, and a neurological
work up was performed. Moreover, each subject underwent blood sam-
pling for Notch3 genotype determination.
Results Notch3 genotypes as well as allele frequencies did not differ
in migraine patients compared to controls, even adjusting for the pres-
ence of possible confounders. No difference was found either in
migraine patients with or without aura.
Conclusions These findings support the view that the functional poly-
morphism T6746C in the Notch3 gene is not involved in increasing the
risk of migraine or migraine subtypes.
HOMOCYSTEINE AND MIGRAINE: CORRELATIONS WITH
CLINICAL, NEUROPHYSIOLOGICAL AND NEURORADIO-
LOGICAL FEATURES
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Introduction Increased homocysteine levels are associated with vari-
ous pathological conditions in humans, including stroke and cardiovas-
cular disorders. An association between the homozygous C677T muta-
tion in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene
and serum homocysteine levels [1] has been detected. In previous stud-
ies, an over-representation of the 677T allele was observed in migraine
patients compared to controls, specifically for the migraine with aura
(MA) subtype [2]. Homocysteine acts as an excitatory amino acid  and
may influence the threshold and the evolution of migraine headache. 
Objective This study was designed to determine the influence of
homocysteine levels and the homozygous C677T mutation on: (1) the
factors predisposing to migraine, evaluated with the steady-state visu-
al-evoked response and the habituation of Contingent Negative
Variation (CNV); (2) the severity of migraine, evaluated with the
MIDAS scale and the mean frequency of headache in the last 3 months;
and (3) the MRI picture.
Methods The MTHFR C677T variant was genotyped in 75 migraine
without aura (MO), 15 MA patients, and 100 controls. In all cases,
CNV habituation and somatosensory visual-evoked potentials
(SSVEPs) to medium and high frequency stimulation patterns were
evaluated; twenty controls negative for the MTHFR gene were admit-
ted for neurophysiological examination. Eighty patients were also
admitted for MRI study. 
Results We observed an over-representation of the 677T allele in
migraine patients compared with controls, more evident for the MA
subtype: the MTHFR variant was also associated with reduced habitua-
tion pattern of CNV and enhanced photic driving. Higher levels of
homocysteine were linked with earlier onset of migraine, higher fre-
quency of headache, and multiple gliotic, peri-ventricular areas on MRI.
Discussion The MTHFR variant seems to be linked with greater sever-
ity of both MA and MO and increased migraine susceptibility: this
finding may be reinforced by increased levels of homocysteine, which
may cause impaired release of nitric oxide and increase the firing rate
of trigeminal neurons, factors involved in the initiation and mainte-
nance of migraine.
Conclusions The MTHFR gene variant seems to enhance the suscep-
tibility to migraine and to worsen its evolution.
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Background A deficit of habituation for different sensory modalities,
including somatosensory, characterizes migraine patients between
attacks. Interestingly, this abnormal cortical information processing
normalizes during an attack. Since the exact mechanisms of this elec-
trophysiological phenomenon are still under debate, we have studied
the high-frequency oscillations (HFOs) embedded in somatosensory
evoked potentials (SSEPs) because they are thought to reflect spike
activity in thalamo-cortical cholinergic fibers (early HFOs) and in cor-
tical inhibitory GABA (gamma-aminobutyric acid)-ergic interneurons
(late HFOs).
Subjects and methods Forty-two untreated migraine patients with
(MA) and without (MO) aura were recorded during (n=13, 9 MO, 4
MA) and between attacks (n=29, 14 MO, 15 MA) and compared with
15 healthy volunteers (HV). SSEPs were filtered off-line (digital band-
pass between 450 and 750 Hz) to extract the two HFO bursts from the
broad-band contralateral N20 somatosensory cortical response,
obtained always by right median nerve stimulation.
Results Amplitudes and latencies of conventional broad-band SSEPs
recorded in migraine patients between attacks from cervical and pari-
etal active electrodes were not significantly different from those found
in HV. In contrast, maximum peak-to-peak amplitude and area under
the rectified curve of the early HFO burst were significantly smaller in
both MO and MA patients than in HV. There was no significant differ-
ence in the later HFO burst between migraineurs and HV. During
attacks, all electrophysiological measurements in migraineurs were
similar to those found in HV.
Discussion These results support the hypothesis that a reduced pre-
activation level of sensory cortices explains the lack of habituation
phenomenon in migraineurs, and not cortical hyperexcitability or
reduced intracortical inhibition.
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Conclusions These results suggest that evoked activity in thalamo-cor-
tical excitatory cholinergic afferents is interictally decreased in both
migraineur groups, but normalises during an attack; whereas intracor-
tical inhibition, as indexed by the late HFO burst, is normal at any time.
THE DIFFUSE NOXIOUS INHIBITORY CONTROL SYSTEM
IN CHRONIC MIGRAINE TESTED BY MODULATION OF THE
BLINK REFLEX BY REMOTE PAINFUL CONDITIONING
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Introduction A dysfunctional activation of brainstem structures
inhibiting pain transmission was postulated in chronic migraine [1].
The R2 component of the blink reflex is a very tempting model to
explore trigeminal nociception [2]. The aim of the study was to test
the function of the diffuse noxious inhibitory control system (DNIC)
in chronic migraine, exploring the R2 suppression induced by
painful stimulation of the hand, obtained by topical application of
capsaicin.
Methods Thirty headache patients were selected, 10 were affected by
migraine without aura, 10 by chronic migraine and 10 by chronic
migraine with analgesic overuse. Ten control subjects were also evalu-
ated. All patients were free from migraine during the evaluation. The
blink reflex was elicited by electrical stimuli delivered to the right
supraorbital nerve, settled at an intensity 2 mA over the threshold of the
R2. Therefore, the R2 response was obtained 10 min and 20 min after
the application of 1 ml of 3% capsaicin in a cream base (Teofarma) on
the skin of the dorsum of the right hand, within an area of 3 cm2. All
patients were requested to rate the pain induced by capsaicin using a
0–100 visual analogue scale (VAS).
Results In control subjects the integral of R2 was reduced by about
15%, while the rate of R2 suppression after conditioning painful stim-
ulation was on average 12% in migraine without aura patients, 7% in
chronic migraine, and 2% in chronic migraine with analgesic overuse.
Chronic migraine rated the capsaicin elicited pain with higher VAS
scores with respect to controls. In the whole migraine group, the rate
of R2 suppression was significantly reduced with the increase of illness
duration and headache frequency. The rate of R2 suppression was also
significantly correlated with the subjective rating of capsaicin induced
pain in patients and controls. 
Discussion and conclusions These data could suggest that the dys-
function of inhibitory control of pain may be intrinsic to migraine, but
it can predispose to chronic migraine and analgesic overuse. It may be
linked with the phenomenon of generalized hyper-algesia, which may
persist outside the attack, leading to a self-outstanding circuit favour-
ing the maintenance of headache. 
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Background In migraine patients, sensitisation of the spinal trigeminal
nucleus neurons has been hypothesised during an attack (Burstein et
al., Brain 2000; Kaube et al., Neurology 2002). There is also some evi-
dence that such sensitisation could persist for some time between
attacks. A deficit of habituation was detected in migraineurs for a brain
stem reflex, the nociceptive specific blink reflex (nBR) (Katsarava et
al., 2003): the question arises whether this phenomenon could be relat-
ed to peripheral or central sensitisation in the trigeminal system. The
R2 response can be suppressed by prior stimulation of the supraorbital
nerve and its recovery curve after paired stimuli depends on the
excitability of the trigemino-facial circuit. Moreover, the R2 response
can be suppressed also by peripheral nerves (Rossi and Scarpini,
1992), via activation of inhibiting central reticular nuclei (Valls-Solé et
al., 1994). In order to shed light on the mechanisms of the interictal
brainstem dysfunction in migraine, we have studied recovery curves of
the R2 component of the nBR after conditioning by supraorbital or
index finger stimuli in untreated migraine without aura patients (MO)
between attacks and in healthy volunteers (HV).
Subjects and methods We recorded the recovery curve of the R2 nBR
in 14 MO patients and in a group of 15 HV, in a first session by paired
supraorbital identical stimuli, and in a second after a single shock
delivered through ring electrodes to phalanges I and II ipsilateral to the
preceding supraorbital stimulus. Both conditionings were performed at
interstimulus intervals (ISI) ranging from 50 to 600 ms, which allowed
computation of a recovery curve.
Results The nBR recovery curves were normal for both the paired
supraorbital and the peripheral index finger stimuli in migraineurs
compared to healthy volunteers.
Conclusions These results are not in favour of persistent interictal sen-
sitisation in the spinal trigeminal sensory system. They also suggest
that the control of medullary R2 interneurons, notably by descending
brainstem pathways, is normal in migraine between attacks. Therefore,
neither central nor peripheral sensitisation are likely to be responsible
for the interictal habituation deficit of the nociceptive blink reflex in
migraine patients.
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Background Two abnormal visual information processings character-
ize migraine patients between attacks: habituation deficit to repetition
of the same stimulus, and the experience of more discomfort during
visual stimulation, e.g. environmental light and pattern reversal on a
screen. Pre- and post-synaptic or pre-cortical and cortical contributions
have been hypothesized in the generation of visual-evoked oscillations
in the gamma frequency range (GFOs, 20–60 Hz) (Carozzo et al.,
2004). Moreover, these GFOs may underlie the perception of visual
discomfort (Adjamin et al., 2004).
Subjects and methods We extrapolated the GFOs from the broad-
band visual-evoked potentials (VEPs) with an off-line band pass dig-
ital filter (20–35 Hz) in a group of healthy volunteers (HV, n=15),
and in a group of migraine with (MA, n=15) and without aura (MO,
n=15) patients between attacks. We analysed peak-to-peak amplitude
and habituation (the amplitude change (%) between the 1st and 6th
block of 100 sequential averaged responses) of the conventional
broad-band N1-P1 and every 6 peaks of GFO bursts evoked by a
checkerboard pattern.
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Results Amplitude of the 3 early components in the 1st block (100
sweeps) was significantly increased only in MA patients (p=0.03). There
was significant habituation deficit of the late GBO peaks, but not of the
early ones, in migraineurs (MA and MO) compared with HV (p<0.05).
Conclusions The lack of habituation of the late GFO burst mimics that
of the broad-band VEP and suggests that postsynaptic mechanisms are
responsible for this most reproducible abnormality of sensory process-
ing in migraine. However, it could also be hypothesized that the
increased amplitude of early GFO is related to the visual discomfort
commonly experienced in migraineurs, more frequently in MA.
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION
(RTMS) MODULATION OF THE VISUAL CORTEX OF
HEALTHY SUBJECTS UNDERGOING LIGHT DEPRIVATION:
A HUMAN MODEL TO STUDY THE PATHOPHYSIOLOGY OF
MIGRAINE
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Introduction We reported paradoxical facilitation by 1 Hz rTMS in the
visual cortex of migraineurs with aura and interpreted these results as
due to inefficiency of the inhibitory circuits, unable to be up-regulated
by low-frequency rTMS [1, 2]. Light deprivation (LD) is known to
increase visual cortical excitability through down-regulation of GABA
circuits. On this basis, we investigated rTMS modulatory effects in nor-
mal subjects undergoing LD with the following aims: first, to explore
further the effects of LD on visual cortex excitability; and second, to
evaluate if, in a condition of reduced inhibition such as LD, healthy
subjects show paradoxical effects like those reported in migraineurs.
Subjects and methods Six healthy subjects reporting reliable induc-
tion of phosphenes by occipital TMS underwent 60 min of complete
LD. Phosphene threshold (PT) was measured before (T0), after 45 min
(T1) and 60 min (T2) of LD, and then every ten minutes after light re-
exposure until recovery to T0 values. Repetitive TMS (at 1Hz or 10
Hz) was applied in separate sessions in the last 15 min of LD. PTs sig-
nificantly decreased after 45 min of LD. rTMS differentially modified
the effects of 60 min LD on PTs depending on stimulation frequency.
1 Hz rTMS did not change the decreasing of PT values as observed in
baseline condition, but significantly prolonged the time to recover T0
PT values after light re-exposure. By contrast, 10 Hz rTMS signifi-
cantly increased PT and the time to recover T0 PT values after light re-
exposure was shortened.
Conclusions The results of this study show that the modulatory effects of
different rTMS frequencies on visual cortex critically depend on the pre-
existing excitability state of inhibitory and facilitatory circuits. Indeed,
during LD healthy subjects behave like migraineurs and this could pro-
vide a useful human model to study the pathophysiology of migraine.
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Introduction Motor cortex excitability changes have been reported in
migraine and numerous studies have yielded interesting, but partly
controversial results. We employed focal TMS to evaluate motor cor-
tex excitatory and inhibitory properties in unilateral migraine patients.
Patients and methods Motor Evoked Potentials (MEPs) were record-
ed from the ADM muscle of 14 patients (40±8.2 years) with unilateral
migraine with or without aura (frequency attack 1–7/month). TMS was
performed 2 days after the last attack. Seven patients had a post-TMS
headache within 24 hours following the TMS recording (subgroup A =
post-TMS attack), whereas 7 patients did not (subgroup B = no post-
TMS attack). The following TMS parameters were analysed in both
hemispheres and compared to those of 10 healthy subjects: (a) resting
motor threshold (RMT); (b) cortical silent period (CSP) duration at
threshold (100%) and from 110% to 180% of threshold values; (c)
short- (S-ICI=1–3 ms) and long- (L-ICI=80 ms) intracortical inhibition
to paired-TMS.
Results RMT, S-ICI and L-ICI were not significantly different
between the two subgroups of patients and between patients and con-
trols. CSP duration at threshold was significantly shorter in subgroup
B (no post-TMS attack) than A (post-TMS attack; p< 0.05). In sub-
group A, CSP duration increased linearly from 110% to 180% of
threshold intensity. Such a stimulus intensity/silent period duration
curve was very similar to that observed in normal subjects. Conversely,
in patients without post-TMS attack, the linear CSP progression was
interrupted at TMS intensities of 140% above threshold. 
Discussion Abnormalities of inhibitory motor cortex circuits as
revealed by CSP duration analysis were found in both hemispheres of
patients with no migraine attack after TMS recordings. In contrast, in
patients with post-TMS headache, no abnormalities were observed.
Conclusions Our findings confirm that the motor cortex is dysfunc-
tioning interictally in unilateral migraine. Furthermore, from our data
we speculate that a “time window” could exist next to the migraine
attack, during which motor cortical inhibitory mechanisms tend to
normalise. 
PHYSIOPATHOLOGICAL ASPECTS OF HEADACHES II
CEREBROSPINAL FLUID LEVELS OF ANANDAMIDE AND
PALMITOYLETHANOLAMIDE SUGGEST A FAILURE OF THE
ENDOCANNABINOID SYSTEM IN CHRONIC MIGRAINE
WITH AND WITHOUT ANALGESIC OVERUSE
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Background Cannabinoid receptors and their endogenous ligands con-
stitute a novel modulatory system that is involved in specific brain
functions, such as control of movement, memory, neuroendocrine reg-
ulation, and also nociception [1]. Based on experimental evidence of
the antinociceptive action of endocannabinoids and their role in mod-
ulating trigeminovascular system activation, we hypothesized a dys-
function of this system in chronic migraine. 
Objectives We determined the levels of the endogenous cannabinoids
arachidonoylethanolamide (anandamide, AEA), palmitoylethanolamide
(PEA) and 2-arachidonoylglycerol (2-AG) in the cerebrospinal fluid
(CSF) of 15 patients with chronic migraine (CM), 15 patients with prob-
able chronic migraine and probable analgesic-overuse headache
(PCM+PAAH), and 15 controls.
Methods Endogenous cannabinoids were purified from CSF by high-
performance liquid chromatography, and quantified by isotope dilution
gas-chromatography/mass-spectrometry. CGRP levels were also deter-
mined by RIA method and nitrites by HPLC.
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Results CSF concentrations of AEA and PEA were significantly lower
in CM and PCM+PAAH patients than in controls (p<0.01 and p<0.02,
respectively). In contrast, the levels of 2-AG were below detection in
both patient and control groups. A negative correlation emerged between
AEA and PEA and both CGRP and nitrite levels in both patient groups. 
Conclusions Reduced levels of anandamide and palmitoylethanolamide
in the CSF of CM patients suggest failure of the endogenous cannabinoid
system and intercellular signalling that may contribute to chronic head
pain, which seems to be related to increased CGRP and NO production.
This can be related to a failure of the inhibitory role of AEA on trigemi-
novascular system activation via CB(1) receptors localized on fibres in
the spinal trigeminal tract and spinal trigeminal nucleus caudalis. The
failure of the inhibitory role of AEA and also of PEA can therefore con-
tribute to maintaining central sensitization in chronic head pain together
with NGF and BDNF release via glutamatergic transmission, reflected in
higher levels of the sensory neuropeptide CGRP and NO production. The
above findings support the potential role of the CB(1) receptor as a pos-
sible therapeutic target in these patients [2].
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NOCICEPTIN LEVELS IN CEREBROSPINAL FLUID OF
CHRONIC MIGRAINE AND FIBROMYALGIA PATIENTS
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Study background Nociceptin is the endogenous ligand of the G-cou-
pled naloxone-insensitive ORL-receptor. An increased expression of
both nociceptin and ORL(1) receptors has been demonstrated in the
dorsal horn of rat spinal cord in experimental pain models, thus indi-
cating the involvement of the nociceptin/ORL(1) system in the mech-
anisms of pathological pain [1].
Objective The present study was aimed at investigating the cere-
brospinal fluid (CSF) levels of nociceptin and PGE2 in 20 chronic
migraine (CM) patients, 20 patients with probable chronic migraine
(PCM) and probable analgesic-abuse headache (PAAH), and 20
patients affected by primary fibromyalgia syndrome (PFMS). Control
values for nociceptin and PGE2 were obtained from the CSF of 20 sub-
jects, for whom laboratory and instrumental investigations excluded
diseases of the central and peripheral nervous systems.
Methods CSF nociceptin and PGE2 levels were determined by sensi-
tive immunoassays.
Results Nociceptin and PGE2 levels were significantly higher in the
CSF of patients with CM, PCM+PAAH and PFMS compared with con-
trols (nociceptin = p<0.01, p<0.02, p<0.01; and PGE2 = p<0.03,
p<0.02, p<0.01, respectively), without significant differences among
patient groups. A significant correlation emerged between CSF noci-
ceptin and PGE2 levels in CM (R=0.62, p<0.01) and PCM+PAAH
(R=0.60, p<0.02) patients and also PFMS patients (R=0.48, p<0.01).
Discussion Nociceptin/orphanin FQ (noci/OFQ), the endogenous lig-
and for the orphan ORL(1) (opioid receptor-like1), has been shown to
be anti- or pronociceptive and modifies morphine analgesia in rats after
central administration. A pronociceptive action of nociceptin related to
PGE2 secretion can be hypothesized in both chronic migraine and
fibromyalgia, where it seems not to be influenced by analgesic abuse
but rather is related to chronic pain per se [2].
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EFFECTS OF DISTRACTION ON ANALGESIA AND SPATIAL
DISCRIMINATION OF PAINFUL STIMULI IN MIGRAINE
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1Neurologic and Psychiatric Sciences Department, University of Bari, Bari,
Italy; 2Institute of Physiology and Pathophysiology, Johannes Gutenberg
University, Mainz, Germany; e-mail: m.detommaso@neurol.uniba.it
Introduction In a previous study on laser-evoked potentials (LEPs) in
patients with migraine without aura (MO) and chronic migraine (CM),
a reduced effect of distraction in suppressing the cortical response to
painful stimuli was detected in both MO and CM [1].
Objective The aim of this study was to test the effects of arithmetic
tasks on spatial discrimination of painful laser stimuli and pain sensi-
tivity in a cohort of MO and CM patients, compared to healthy controls. 
Subjects and methods Ten MO and 10 CM patients were examined in
a pain-free period and compared to 10 age- and sex matched controls.
Four series of 20 laser pulses were  applied on the dorsum of the left
and right hands, onto two parallel lines located on the ulnar and radial
side. All subjects were asked to perform spatial discrimination tasks
(ulnar or radial side) after each laser stimulus, using two levels of task
difficulty to emphasize the sensory-discriminative aspect of pain, also
specifying the subjective pain rating according to a visual analogue
scale 0–100. In 1 run taken randomly for both hands in the two levels
of task difficulty, spatial discrimination tasks were contrasted with
active distraction by mental arithmetic, consisting of serial subtractions
of four-digit-numbers in steps of 7 or 9. Electroencephalogram (EEG)
was recorded by 25 electrodes, placed at the 19 standard positions of
the international 10/20 system, with 6 adjunctive electrodes.
Results The discrimination ability was the same across the three groups,
but the effects of distraction on pain sensitivity was significantly
reduced in both MO and CM groups in respect to controls. CM patients
showed a slightly reduced ability in arithmetic tasks in respect to con-
trols, and the effects of distraction on spatial discrimination was reduced
in respect to normal controls. The rate of amplitude suppression of LEPs
was also reduced in CM patients during mental arithmetic tasks.
Discussion and conclusions A reduced analgesic effect of distraction
was confirmed in migraine: in CM patients, a slightly reduced arith-
metic ability was linked with higher spatial discrimination of painful
stimuli. This phenomenon may be attributed to enhanced activation of
the cortical areas underlying the attentive components of pain, and it
may also be favoured by slight cognitive impairment linked with the
progression of migraine.
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ENHANCED TRIGEMINO-CERVICAL-SPINAL REFLEX
RECOVERY CYCLE IN PAIN-FREE MIGRAINEURS
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Introduction Trigemino-cervical-spinal reflexes (TCSRs) are part of a
complex nociceptive response involving the cervical and the upper
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limb muscles, and are modulated by supraspinal inhibitory pathways;
it may thus be possible to use TCSRs to explore the trigeminal system
in migraineurs. The aim of the present study was to evaluate TCSRs in
a group of migraine patients during the pain-free period.
Patients and methods Forty-three migraine patients, 32 without aura
(MO), and 11 with aura (MA) and 30 age- and sex-matched healthy
subjects took part in the study. TCSRs were obtained by stimulating the
supraorbital nerve (SON) and recording from the semispinalis capitis
muscle and the biceps brachii. The latency (L, ms), area (A, mVms)
and recovery cycle of the reflexes were recorded. The effects of het-
erotopic painful stimulation on the neurophysiological parameters
were studied by a validated cold pressor test (CPT).
Results No significant changes were found between either migraine
patients and controls or MO and MA patients in the mean values of L and
A of TCSRs (t-test, p>0.05). The recovery curve of the trigemino-cervi-
cal reflexes (TCRs) was significantly faster in migraine patients than in
controls, while no differences were found in the trigemino-spinal reflex-
es (TSRs) (t-test, p<0.01). Activation of the diffuse noxious inhibitory
controls (DNICs) through the CPT induced a significant reduction in the
areas of the TCRs and TSRs in both migraine patients and controls
(paired t-test, p<0.01), though the extent of this reduction did not differ
significantly between migraineurs and controls (t-test, p>0.05).
Conclusions Our data suggest that the pain-free period in migraine
patients is characterised by hyperexcitability of the trigeminal path-
ways and of their anatomical and functional connections with the upper
cervical cord neurons, and that this abnormal hyper-excitability does
not appear to be due to a lack of supraspinal inhibitory modulation.
NEUROENDOCRINE FUNCTION IS ALTERED IN PATIENTS
WITH CHRONIC MIGRAINE AND MEDICATION-OVERUSE
HEADACHE
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Introduction Chronic migraine (CM) is a major health problem. CM
is frequently associated with psychiatric comorbidity, like anxiety and
depression, and often complicated by overuse of acute medication
drugs. The effects of analgesic overuse on endocrine functions in CM
patients are still unknown. The purpose of this study was to investigate
neuroendocrine function in patients with CM and medication-overuse
headache (MOH).
Subjects and methods Eighteen patients (15 women, 3 men; mean
age±SD = 44.3±9.9 years) with CM and MOH, diagnosed according to
ICHD-II criteria, and 18 healthy controls (15 women, 3 men; mean
age±SD = 40.3±7.9 years) received intravenous administration of
GHRH, hCRH, and TRH. Plasma concentrations of GH, TSH, ACTH
and cortisol were measured in a 90 min period after administration of
the specific releasing hormones.
Results Hormonal baseline concentrations were similar in both groups.
GH response to GHRH was significantly reduced in patients with CM-
MOH in comparison with controls. After hCRH administration, ACTH
and cortisol concentrations were significantly higher in patients than in
controls. A significant positive correlation (r=0.61, p=0.028) between
duration of disease and altered hormonal response was found.
Discussion Our study indicates that, in patients with chronic migraine
and abuse of analgesic drugs, hypothalamic control of corticotropic
and somatotropic functions is significantly altered. These findings are
in accord with a previous study showing an abnormal pattern of spon-
taneous hypothalamic hormonal secretion in patients with CM. A rela-
tionship between altered hormonal secretion and some of the clinical
symptoms of patients with CM-MOH may be hypothesised.
Conclusions Our data support a role for the hypothalamus in the mech-
anisms of migraine chronicity and suggest the need for additional stud-
ies evaluating the relationship between abuse of antimigraine drugs
and hormonal alterations in chronic migraine.
CLINICAL ASPECTS OF HEADACHES I
PREVALENCE OF HEADACHE IN A GROUP OF 1000
PATIENTS AT FIRST VISIT TO A TERRITORIAL NEUROLOG-
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Introduction Headache is one of the most common types of neurolog-
ical symptoms that patients complain of to the neurologist; in fact, pre-
vious studies suggest that headache is one of the main reasons for vis-
iting a neurological office. Our clinic is in Bagheria (Sicily) and serves
a population of more than 80 000 people. The aim of this study was to
determine how many patients at first visit had headache as a dominant
symptom.
Patients and methods We retrospectively analysed the clinical records
of 1000 consecutive patients who came to our office for the first time
for a neurological examination. We did not use any other criterion for
selection.
Results The mean age of Group A was 60 years (range 18–94); 590
(59%) were woman, 410 (41%) men, and 46.1% of patients were over
65 years of age. Headache was the reason for the visit in 176 (17.6%)
patients (50 M, 126 F). Group B was composed of patients aged 18 to
65 years (mean age 45), 330 women and 209 men, of whom 139
(25.8%) suffered from headache (28 M; 101 F). In Group A, 12.2% of
males and 21.3% of females suffered from headache, whereas in
Group B, 13.4% of males and 30.6% of females were affected by
headache. The males who had headache were 12.19% in Group A and
13.39% of all in the Group B, the females were 21.3% in Group A and
30.6% in  Group B.
Discussion and conclusions This epidemiological study confirms that
headache is the most common reason for visiting in adult neurological
patients and the prevalence of this disease increases in the group aged
18 to 65 years. In terms of percentages, there was a small difference
between the two male age groups (>1.20% in Group B), whereas we
found a major female preponderance in Group B (>9.3%). Presumably,
migraine prevalence increases more rapidly in women, from menarche
to about the age of 40 due to alterations in hormonal levels, after which
prevalence decreases with respect to men.
EVALUATION OF HEADACHE FREQUENCY: A COMPARI-
SON BETWEEN TWO METHODS
L. Savi, P. De Martino, L. Pinessi
Primary Headache Centre, Neurology III, Department of
Neurosciences, University of Turin, Molinette Hospital, Turin, Italy; e-
mail: lsavi@molinette.piemonte.it
In the management of the headache patient an accurate evaluation of
headache frequency is very important for many different reasons (e.g.,
to decide if a prophylactic treatment is necessary, to identify the best
drug to be used, to evaluate treatment efficacy, etc.). It is possible to
obtain this information directly from the patient’s history, or from the
patient’s headache diary. To determine if these two methods are equiv-
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alent, a group of 523 headache patients (390 females and 124 males,
age range 15–71 years, mean age±SD = 37.42±12.42 years), of whom
250 (190 females and 60 males, mean age±SD = 35.86±12.05 years)
suffering from migraine without aura (MO) and 273 (209 females and
64 males, mean age±SD = 38.83±12.8 years) suffering from coexisting
MO and episodic tension-type headache (ETTH), diagnosed according
to ICHD-II criteria, were studied. All patients were asked how many
days with headache they usually had in a 4-week period. Then, each
patient had to record all the days in which he/she experienced headache
in a 4-week period headache diary. Headache frequency assessed by an
interview was compared with that obtained from the diary. The two
data were considered corresponding when the difference did not
exceed 2 days (more or less), otherwise they were considered not cor-
responding. The patients in both groups were also subdivided into sub-
groups based on age and sex. In 295 (56.4%) patients, the headache
diary data matched those provided by the interview. This correspon-
dence was almost the same in all the different groups studied. When the
data did not correspond, patients suffering from coexisting MO and
ETTH generally recorded a higher number of days with headache in
the diary than the one derived from the interview more often than MO
patients (p<0.001). In conclusion, while both these methods can be
used to determine headache frequency, they do not correspond exactly.
Since, in our experience, both methods can be imprecise, it is always
better to combine them. 
EMOTIONS IN PRIMARY HEADACHE: A PRELIMINARY
STUDY
1M. Grobberio, 2A.H. Cronin, 2F. Di Palma, 2R. Sterzi
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Background Recent studies suggest a growing interest in the relation-
ship between headache and psychological aspects [1, 2]. In order to
underline that psychological information might be useful in treating such
patients, we analysed both psychological symptoms and the emotional
profile of our headache patients. A further aim of this study was to define
if emotional or psychopathological traits might influence perception of
quality of life. We report our preliminary data on the first patients.
Patients and methods Five female patients with primary headache (3
migraine without aura (MO); 1 tension-type headache (TTH); 1 anal-
gesic rebound headache (ARH)) were studied with a global psycho-
logical assessment. Minnesota Multiphasic Personality Inventory–2
(MMPI-2), Cognitive Behavioral Assessment (CBA), Profile of Mood
States (POMS) and Short Form–36 (SF36) were administered. Patients
also underwent a psychological-clinical interview. Non parametric cor-
relations (r Pearson), qualitative analysis of data and clinical profile
observation were performed.
Results Our patients showed high levels in MMPI-based scale 1
(Hypochondriasis), 7 (Psychasthenia) and 8 (Schizophrenia), in
MMPI-content scale HEA (Health Worry), in POMS-factor T
(Tension-anxiety) and A (Anger). On the contrary, they showed low
levels in SF36-subscales RF, DF and AS. CBA did not add any signif-
icant information. SF36-AS subscale correlates with MMPI-based
scale 3 (Hysteria: r=-0.936, p=0.019), MMPI-content scale HEA (r=-
0.881, p=0.049) and POMS-V factor (r=.947, p=0.014). POMS-T fac-
tor correlates with MMPI-based scale 6 (Paranoia: r=0.939, p=0.018),
MMPI-content scale ANG (r=0.988, p=0.002) and POMS-D factor
(r=0.948, p=0.014).
Discussion According to the literature, our patients confirm high anx-
iety levels in formal psychological testing [3]. This agrees with the
diagnosis of anxiety disturbances according to DSM-IV, as emerged
from the psychological-clinical interview, even though some subclini-
cal depressive symptoms might appear. Our data suggest that quality of
life is not influenced primarily by pain perception itself, but by worries
about pain-related fear. This seems to limit social interactions by
avoidance behaviour [4] and to determine general reduction of self-
esteem. Moreover, our patients showed an important impairment in
emotional focusing due to a more selective attention to somatic symp-
toms and mental distress. 
Conclusions Our data may suggest that individual cognitive-behav-
ioural psychotherapy and/or supervised mutual self-help groups could
be the right tools to improve emotional recognition in headache
patients. This might influence quality of life perception and the com-
pliance to medical treatment.
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WORK-RELATED INJURIES AND HEADACHE AMONG HOS-
PITAL EMPLOYEES
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Introduction The Constitution regulates and protects workers also in
work accidents. The work accident is defined as an accidental event
that happens from a violent cause during work which causes an injury.
Aim The objective of the present study was to monitor the headache
frequency in a hospital environment in employees who had reported
work-related injuries.
Subjects and methods This open, observational, and prospective
study was conducted at the IRCCS “C. Mondino” of Pavia, from
January to December 1990, involving 252 hospital employees. All
employees who had reported accidents, including employees who were
never absent from work (0 days prognosis) were considered. The study
involved all patients with headache visited by an occupational physi-
cian for injuries which occurred while working. A schedule for noso-
graphic framing of headache based on IHS criteria (1988) was admin-
istered to workers who suffered from headache during the periodic
control visits (Health Survey Protocol).
Results A total of 156 work-related accidents were registered, with an
accident incidence of 1 per month, and 1847 total days of absence from
work (mean days/injury 11.84). In the injured population (64 M, 92 F;
mean age 34.3±6.8 years), 41 were headache sufferers (13 M, 28 F;
mean age 38±8.7 years). The headache subtype distribution was: 2
episodic cluster headaches, 15 episodic tension headaches, and 24
migraine without aura. Among these, 5 migraine without aura and 3
episodic tension headache subjects had 2 injuries and 1 migraine with-
out aura subject had 3 injuries. The most frequent accident was the nee-
dle prick, and the most serious was that occurring during working
activities or “in itinere”.
Discussion Data show that the frequency of headache among workers
who suffered an injury is 26.2%. The reduction in attention and the dis-
ability induced by headache or by post-pharmacological effects may be
identified as possible risk factors that cause accidents in workers who
suffer from headache.
Conclusions It is useful that occupational physicians investigate indi-
vidual headache susceptibility during both the pre-hiring phase and
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routine control visits, also in relation to the employee’s work activity.
This study will continue to monitor the presence and/or absence of
headache at the time of injury to further study the relationship between
headache and work injuries.
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Introduction Headache accounts for 1%–3% of admissions to an
emergency department (ED). The majority of patients who present to
an ED with acute primary headache have migraine and little is known
about their disability.
Aim The aim of this study was to evaluate the clinical impact of the
collaboration between headache centre (HC) and ED in the diagnosis
and treatment of migraine. In particular, we aimed to evaluate the dis-
ability of this population before and after a three-month period of ther-
apy in a headache centre (HC).
Patients and methods All the patients admitted to our HC within 48h
after discharge from an ED were included. At admission to our HC,
patient data were collected on the basis of International Headache
Society 2004 criteria (ICHD-II) and they underwent the Migraine
Disability Assessment (MIDAS) (T0). A clinical evaluation was per-
formed at 30 (T1) and at 90 (T2) days from baseline, and at the T2
visit, disability was again re-evaluated with the MIDAS scale.
Results Out of 252 patients admitted to our HC, 202 (47 M/155 F;
age 36±14 years) met ICHD-II criteria for migraine or its complica-
tions (e.g. status migrainosus and/or chronic migraine). Seventeen
percent of migraineurs had previously seen a headache specialist
and 13% had used a triptan before. We observed a T2 follow-up visit
in 52% of migraineurs. From a clinical point of view, we observed
a significant reduction in days/months with headache from 15 at T0
to 5 at T2 (p<0.001). In regards to MIDAS, high level grades at
baseline visit (65% of migraineurs at grade IV) and a significant
reduction of the MIDAS scores at T2 follow-up visit (p<0.0001)
were found.
Conclusions Our data confirm that migraine represents the most fre-
quent primary headache observed in ED and that it is an under-diag-
nosed and under-treated pathology associated with a high level of dis-
ability. In fact, the high percentage of “treatment naïve” patients may
be the main factor responsible for the disability of this peculiar
migraine population. The reduction of headache frequency after 3
months of headache centre therapy together with the improvement in
quality of life as observed in our migraine population support the
importance of a strict collaboration between the HC and the ED in the
diagnosis and therapy of primary headaches.
“HEADACHE WEEK”: A MEETING BETWEEN PATIENTS
AND EXPERTS
V. Raieli, F. Brighina, G. Calagna, M. Calia, F. Consolo, S. Crinò, 
M. Demma, D. Ferrara, M. Francolini, R. Lupo, C. Morreale, 
D. Puma, D. Ragusa, G. Santangelo, F. Serra, G.B. La Pegna*
SISC Regional Group, Palermo, Italy; *President, SISC Regional
Section, Caltanissetta, Italy; e-mail vinzi.raielk@inwind.it
Objectives To better understand patients’ questions about their
headache, we held free meetings in a headache centre for one week.
Methods In a headache centre, several pain experts were available
to answer questions from patients about paediatric and adult
headaches by phone, mail or direct contact. This “Headache Week”
was publicized through journals and posters in hospitals and med-
ical offices.
Results During the week 182 people contacted us, 113 by phone, 58
by direct contact and 11 by mail. Thirty-three questions regarded pae-
diatric headaches, 127 were made by patients under 55 years of age
and 22 by patients over 55 years. One hundred and thirty-six were
females and 46 were males. In this group 133 subjects had migraine,
19 chronic daily headaches, 26 unclassifiable headaches, and 4 other
primary headaches. The most surprising data were that 78% of the
population, even though suffering from high frequency headaches for
several years, had never visited a headache centre or specialist and
had never followed a preventive therapy for their headache. The
major question concerned where they could be visited. Only 22% of
the subjects had been just visited in a headache centre or by a neu-
rologist or other pain specialist. The other most frequent questions
regarded information about other headache centres, new preventive
and symptomatic therapies and potential vascular risks factors.
Discussion These data suggest that our initiative to carry out a
“Headache Week” has been surprisingly useful, not only to answer
questions regarding doubts or curiosities by subjects who had only
been visited by a pain specialist but also to identify the population
of headache patients who had never gone to a specialist and who
often relied on self-medication, risking pharmacological abuse of
symptomatic drugs. The scientific data show that 30% to 70% of
headache patients has not been visited by the doctor and that only
4% had gone to a pain specialist. For these reasons, similar initia-
tives can probably help to direct these patients to a headache centre
and to better inform the general physicians about the headache cen-
tres and the usefulness of a correct symptomatic or prophylactic
therapy for headaches.
CLINICAL ASPECTS OF HEADACHES II
INCREASED VARIANTS OF THE CIRCLE OF WILLLIS IN
MIGRAINEURS
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In recent years, some authors have described an increased proportion
of patent foramen ovale in migraineurs, suggesting the possibility of
a dynamic mechanism in sustaining migraine. Other authors have
reported an increased number of lacunar lesions in some categories
of migraineurs, without any reasonable source of the lesions them-
selves. In consideration of this information, we studied over 100
patients with different types of headaches. We recruited 131 patients
with headache and 18 controls, recruited among patients who under-
went MRI for other reasons. Among patients with headache, 68
patients were migraineurs, 25 had migraine plus another type of
headache, and 38 had a different type of headache. Thirty (44%) of
migraineurs had anatomical variants of the circle of Willis; in this
group, 9 had ischaemic cerebral lesions, whereas only 3 of 13 were
without variants. Among the group of patients with both migraine
and another type of headache, 40% had anatomical variants, whereas
only 21% of patients with other types of headaches and 18% of con-
trols showed anatomical variants. The significantly higher percentage
of anatomical variants of the circle of Willis in patients with migraine
supports the hypothesis that vascular dynamic alterations are associ-
ated with migraine; it may be either an epiphenomenon with possibly
a gene-related linkage, or due to the presence of an anatomical arter-
ial abnormality that could influence headache through vascular
dynamic modifications. 
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THE ROLE OF NEUROIMAGING IN THE EVALUATION OF
HEADACHE PATIENTS: IMPLEMENTATION AND VALIDA-
TION OF THE ITALIAN DIAGNOSTIC GUIDELINES
M.P. Prudenzano, M. Massimo, A. Pignatelli, L. Merico, M. Rossi, 
S. Genco, P. Lamberti, P. Livrea
Headache Disorders Centre, Neurological and Psychiatric Sciences
Department, University of Bari, Bari, Italy; e-mail: m.p.pruden-
zano@neurol.uniba.it 
Introduction In 2001 the Ad Hoc Committee of the Italian Headache
Society published the Italian Diagnostic Guidelines for Migraine and
Cluster Headache [1]. They were based on the diagnostic criteria of the
International Classification of Headache Disorders and provided addi-
tional indications on when neuroimaging procedures are required to
formulate a correct diagnosis and to exclude secondary headaches. The
primary goal of this study was to implement the diagnostic guidelines
for migraine and to validate them on headache patients referring to a
tertiary headache centre. The secondary goal was to evaluate the fre-
quency of white matter lesions whose association with migraine is still
a controversial matter [2].
Subjects and methods All adult headache sufferers consecutively
referred to the Headache Disorder Centre, University of Bari in a one-
year period were enrolled. According to the Italian diagnostic guide-
lines, which were extended also to other types of headaches besides
migraine, magnetic resonance imaging was recommended: (a) in the
presence of focal signs at the neurological examination; (b) to patients
without neurological signs but showing additional risk factors in their
headache history (association with systemic and/or neurological symp-
toms, changes in severity, frequency or clinical features of headache
attacks, new onset of headache after the age of 40 years, recent onset,
progressive worsening course, headache worsening after Valsalva
manoeuvre, and headache not responding to adequate therapies).
Results Specific lesions were found in 13.9% of cases: (venous
angioma 1.9%, cerebellar tonsillar ectopy 1.9%, meningioma 0.8%,
pineal gland cyst 0.2%, silent stroke 2.7%, aneurysm 1.5%, and pitu-
itary microadenoma 0.4%). Among aspecific lesions, white matter
hyperintensities were observed in 15.4% of cases. Among extracranial
lesions sinusitis was the most frequent (13.5%). All patients with silent
stroke were migraineurs. No difference was found in the occurrence of
white matter lesions according to headache type, headache duration,
attack frequency, or concomitant therapy, whereas a more elevated fre-
quency was associated with older age, smoking and hypertension.
Discussion and conclusions Our results showed that the Italian diag-
nostic guidelines are highly sensitive and furnish a correct diagnosis.
The finding of specific lesions allows the physician to plan subsequent
controls and therapies. These results confirmed that magnetic reso-
nance imaging is not recommended routinely but only in those cases
with additional risk factors for secondary headache. The association
between silent stroke and migraine suggests that migraine might be a
vascular risk factor. The results concerning white matter lesions did not
support the hypothesis of a strong link with migraine so further studies
are needed on this topic.
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HEADACHE AND EPILEPSY: DIAGNOSTIC CHALLENGE
AND THERAPEUTIC OPPORTUNITY
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Introduction Headache and epilepsy are chronic neurological disor-
ders with recurrent attacks [1]. Both can include clinical features, such
as: visual disturbances, changes in mood, behaviour, consciousness
and focal sensory or motor symptoms/signs. Sometimes the differential
diagnosis may be difficult. In other cases the two disorders are associ-
ated. The exact prevalence and nature of this comorbidity are not yet
well known. In recent years antiepileptic therapy has been extended
also to headache prophylaxis. This study was carried out with the aim
of assessing the prevalence of headache in patients referring to tertiary
centres for epilepsy care and of evaluating the influence of anticonvul-
sant drugs on headache progression.
Subjects and methods This cross-sectional study was conducted in
the Neurologic Clinics of Bari, Milan, Pisa and in the Psychology
Clinic of Pisa. A broad sample of adult epileptic patients consecutive-
ly referring to the centres was enrolled. Subjects with mental retarda-
tion, or any other psychical and/or medical condition that could limit
their cognitive performance were excluded. A detailed medical history
was collected. Patients underwent physical and neurological examina-
tions, and when necessary, appropriate diagnostic testing. All patients
were asked the following question: “have you ever suffered from
headache?” If the answer was “yes”, a specific headache questionnaire
was administered. Headache was diagnosed according to the criteria of
ICHD-II [2]. Headache was considered as chronic when attack fre-
quency was 15 days or more a month for at least 3 months. Data were
analysed by means of SPSS 11.0 for Windows.
Results About 23% of patients complained of headache attacks related
to seizures; in particular, 5% of headache attacks developed during a
seizure, 30% of them were preictal and 65% were observed in the pos-
tictal period, while for the most part attacks were migraine-like.
Headache and epilepsy were comorbid in 29% of patients. Epilepsy
followed by headache occurred in 60% of patients. Headache onset fol-
lowed by epilepsy onset was observed in 20% of patients. In the
remaining 20% of cases the two disorders began at about the same
time. The prevalence of migraine was about 12%. No chronic headache
was observed in the sample.
Discussion and conclusions Results confirm that headache and epilep-
sy are strongly associated. Neuronal hyperexcitability and low attack
threshold might be involved in both disorders. In this sample, chronic
headache prevalence was lower than in the general population [3], sug-
gesting a possible protective role of antiepileptic drugs not only toward
epilepsy but also toward headache progression.
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MIGRAINE WITH AURA AND ISCHAEMIC STROKE
1F. Mainardi, 1M.C. Mantovan, 1A. Campioni, 1L. Semenzato, 
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Migraine with aura is considered a risk factor for ischaemic stroke in
young people. The relative risk increases in the presence of additional
factors, such as smoking, oral contraceptive therapy, and alterations of
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coagulability, particularly activated protein C resistance and factor V
mutation. A 39-year-old man was admitted to the Emergency
Department because of the onset in the previous 5 hours of a severe pul-
sating headache accompanied by nausea, vomiting, photo- and phono-
phobia. Hemianoptic visual disturbances and a left hemisyndrome pre-
ceded the headache phase. He previously suffered from sporadic hemi-
plegic migraine, according to the ICHD-II criteria. The persistence of
the neurological symptoms and the worsening of the headache, despite
the abortive treatment with triptans, which usually resolved the crisis,
led the patient to medical observation. The neurological examination
confirmed the presence of a left hemisyndrome with a homonymous
hemianopia; consequently, a direct brain CT scan was performed,
which did not reveal any alteration. The presence of an ischaemic
stroke in the region of the right middle cerebral artery was detected
with a second brain CT scan, performed 20 hours after onset of the
symptoms. Routine laboratory tests, auto-antibodies (including
antiphospholipid antibodies), homocysteinemia, ECG, transthoracic
and transaesophageal echocardiography, and Doppler ultrasound of the
supraortic and intracranial vessels resulted normal. An activated protein
C resistance led to investigate the presence of a factor V mutation,
which revealed a homozygous point mutation, G-A1691. In the follow-
ing days, the neurological examination improved, and the patient was
discharged with anticoagulant therapy. Although several studies indi-
cate a relationship between genetic prothrombotic abnormalities and
migraine, this correlation is not demonstrated by definitive evidence.
Nevertheless, it is useful to perform a complete haemocoagulative
screening in patients suffering from migraine with aura. Furthermore,
the persistence of aura symptoms in patients with a well-known diag-
nosis of migraine with aura should be carefully investigated.
MIGRAINE AND MULTIPLE SCLEROSIS: THE ROLE OF
BRAINSTEM DEMYELINATING LESIONS IN THE CAUSA-
TION OF HEADACHE
L. Locatelli, M. Zorzon, A. Granato, C. Maggiore, A. Bratina, 
A. Bosco, G. Relja
Department of Clinical Medicine and Neurology, U.C.O. Neurologic
Clinic, University of Trieste, Trieste, Italy; e-mail: antonio_granato@
hotmail.com
Background Few studies investigated the prevalence of migraine,
diagnosed according to the diagnostic criteria of the International
Headache Society (ICHD-II), in patients with multiple sclerosis (MS).
In case-control studies, prevalence was significantly higher in MS
patients than in controls and ranged from 21% to 27%. Some studies
have highlighted the role of brainstem grey matter dysfunction in gen-
erating migraine attacks. In patients with MS, the brainstem is fre-
quently affected by demyelinating lesions, which could interfere with
brainstem antinociceptive functions.
Objective To study, by quantitative analysis of MR images, the exten-
sion of demyelinating lesions in the brainstem of patients with MS
(diagnosed according to McDonald’s Criteria) with or without migraine.
Patients and methods Eighty-one patients (53 F and 28 M) with MS
underwent a 1.5 tesla brain MRI examination of the brain. Axial
images were obtained with 5mm slice thickness using PD/T2 weight-
ed SE sequences. T2-lesion load (LL) was calculated by an investiga-
tor blinded to patient’s clinical status using a highly reproducible,
semiautomated local thresholding technique for lesion segmentation.
Migraine was diagnosed according to the ICHD-II.
Results Fifteen of 27 (55.5%) MS patients with migraine compared
with 25/54 (46.3%) MS patients without migraine had demyelinating
lesions in the brainstem (p<0.05). The OR for a MS patient with a
demyelinating lesion in the brainstem suffering from migraine was
1.45 (C.I. 95% 1.15-1.8). Brainstem mean T2-LL did not differ in MS
patients with or without migraine (0.222 ml vs. 0.175 ml, p=NS). No
differences were found between MS patients with or without migraine
when calculating the mean T2-LL separately in the midbrain, pons, and
medulla oblongata. There was no relationship between the predomi-
nant side of migrainous headache and the demyelinating lesion side in
the brainstem.
Conclusions MS patients with demyelinating lesions in the brainstem
are at risk for migraine. The extension and the side of demyelinating
lesions seem to have less impact.
PHARMACOEPIDEMIOLOGY OF DRUG USE IN HEADACHE
PATIENTS: COMPARISON BETWEEN SUFFERERS OF MED-
ICATION-OVERUSE HEADACHE AND MIGRAINE
A. Ferrari, S. Leone, A. Bertolini, C.P.R. Coccia, E. Sternieri
Headache Centre, Division of Toxicology and Clinical Pharmacology,
University of Modena and Reggio Emilia, Modena, Italy; e-mail:
annaf@unimore.it
Introduction Chronic headache patients often overuse symptomatic
drugs while episodic headache patients usually take drugs in a very
cautious way. It is unknown if the differences between the two groups
of headache sufferers concern only the amount or also the type of drug
used.
Objective Our aim was to compare the pharmacological habit between
medication-overuse headache (MOH) and migraine patients.
Subjects and methods We compared all drugs taken by (a) 138 MOH
patients (F/M=5.3; mean age±SD: 51±7 years), consecutively admitted
to the in-patient ward of the Headache Centre of the University of
Modena and Reggio Emilia, and; (b) 78 migraine patients (F/M= 2.3;
mean age±SD: 37±10 years) consecutively referred to the outpatient
ward of the Centre. Data were collected by means of a standardized
clinical chart and recorded in an appropriate database. The study was
carried out between June 2004 and March 2005.
Results There were large differences in the types of symptomatic med-
ications used between MOH and migraine patients. In particular, MOH
patients concomitantly took more than one type of symptomatic drug:
triptans, 43.5%; NSAIDs, 42%; association of indomethacin, prochlor-
perazine and caffeine (IPC), 14.5%; and weak opioids, 10%. Migraine
patients used: NSAIDs, 56%; triptans, 30%; IPC, 5%; and other anal-
gesic combinations, 2.6%. In both groups, the most used drugs were
nimesulide and sumatriptan, respectively, among NSAIDs and triptans.
Fifty-eight percent of MOH, and only 20% of migraine patients were
following prophylactic treatments. More than 71% of MOH patients
were also using other medications: antihypertensive agents, 27.5%; ben-
zodiazepines, 27%; antidepressants, 23%; hormones, 23%; antilipemic
agents, 7%; and antiplatelet agents, 6%. Among migraine patients, 54%
were also using other medications: hormones 33%; antihypertensive
agents, 8%; antidepressants, 10%; and benzodiazepines, 5%.
Conclusions Even if MOH often evolves from migraine, our study
indicates that the pharmacoepidemiology of drug use was different
between the two headache forms: MOH patients overused triptans
more than NSAIDs and took multiple medications; migraine patients
took mainly NSAIDs for acute treatment, did not use weak opioids,
and took fewer other medications.
CLINICAL ASPECTS OF HEADACHES III
MEASURING THE DISABILITY IN MIGRAINE
1C. Lisotto, 2G. Zanchin
1Headache Unit, San Vito al Tagliamento, Italy; 2Headache Centre,
Department of Neurosciences, University of Padua, Padua, Italy;
e-mail carlo.lisotto@ass6.sanita.fvg.it
Disability has been defined by the World Health Organization (WHO)
as “any restriction or lack of ability to perform an activity in the man-
ner or within the range considered normal for a human being”. In 2001,
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WHO published the annual World Health Report, using the methodolo-
gy of the Global Burden of Disease study. In this Report, WHO identi-
fied migraine among the top 20 leading causes of years of life lived with
disability (YLDs) in all ages, ranking 12th in females and 19th in both
sexes. Disability refers to the impact of illness on the ability to work and
function in various settings and roles. Information on disability in
migraine complements the diagnosis by helping the physician to assess
the need for treatment. Reduction in headache-related disability is one
of the main goals of the US Headache Consortium Guidelines, which
recommend a stratified care approach based on the level of disability. To
measure the impact of migraine, parameters must be defined that cap-
ture the personal burden on the sufferer and the economic burden on
society. Disability in headache sufferers can be measured with a variety
of generic and specific instruments. Generic tools address a broad range
of life aspects related to health. These instruments can be used for many
diseases and allow for comparison with healthy controls and other dis-
ease populations. However, the generic instruments are often too broad-
based to be responsive to changes in a particular disorder. The specific
tools address in-depth issues more focused on patients’ concerns and are
more likely to be responsive to therapeutic interventions. The most
commonly used generic instruments are the Medical Outcome Study
36-item Short Form (SF-36) and the more recent versions, SF-12 and
SF-8. Among the various specific instruments, the following tools have
been most extensively studied and used: the Henry Ford Headache
Disability Inventory (HDI), the Migraine-Specific Quality of Life
Measure (MSQOL), the Migraine-Specific Quality of Life
Questionnaire (MSQ) and its reviewed new version (MSQ Version 2.1),
the Migraine Disability Assessment (MIDAS), also modified for chil-
dren and adolescents (PedMIDAS), the Headache Needs Assessment
(HANA), and the web-based Headache Impact Test (HIT) and its
derived paper-based short form HIT-6. The use of impact instruments
can improve communication between patients and physicians, aid in the
assessment of migraine severity and in the prescription of an individu-
alised treatment plan in concert with other clinical assessments, and in
the monitoring of the response to therapy.
COMORBIDITY IN MIGRAINEURS IN COMPARISON WITH
PATIENTS AFFECTED BY DIFFERENT TYPES OF
HEADACHES
1C. Cavestro, 2M. De Maestri, 2 G. Giordano, 2M.P. Marino, 2V. Iberti,
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We evaluated 152 consecutive patients referred to the headache service
of our hospital, recording any diseases other than headache in order to
identify any differences in prevalence of such pathological conditions
that could be related to migraine. Of our patients, 84 (70 F, 14 M) were
affected by migraine, 26 (23 F, 3 M) by migraine plus another
headache type, and 42 (31 F, 11 M) by headache different from
migraine. Among the migraineurs, 15 patients had no other patholo-
gies, of whom only 1 patient had a headache frequency of more than
15 days per month, and 3 had a headache frequency of 10 days per
month. Among the patients with migraine and another headache type,
only 1 patient did not have any other disease, and only 2 patients
affected by another headache type did not have other diseases.
Different categories of diseases were evaluated in all groups (disorders
of coagulation, orthopaedic, facial, cervical and spinal disorders, oph-
thalmic and otorhinolaringoiatric, systemic diseases, psychiatric disor-
ders, epilepsy, pathologies that provoke brain lesions, metabolic and
endocrinologic diseases, and others). Comorbidity did not differ in the
three patient groups, except for the absence of additional pathologies in
patients with migraine with low frequency of headache. This suggests
that migraine is primarily an episodic disease, that is, its worsening
should be correlated with the common causes of other headaches.
THE INFLUENCE OF PSYCHIATRIC COMORBIDITY ON
MIGRAINE-RELATED DISABILITY IN A CLINICAL POPULA-
TION OF PATIENTS WITH MIGRAINE WITHOUT AURA
C. Di Lorenzo, F. Cesarino, J. Faroni, P. Rossi 
Headache Clinic, INI Grottaferrata (Rome), Italy; e-mail:
paolo.rossi90@aliceposta.it
Background Previous studies have revealed that migraine-related dis-
ability, as measured by the MIDAS Questionnaire, does not reflect only
migraine intensity and frequency. Factors other than migraine severity
may play a role in determining individual variation in disability levels.
Objective To define predictors of migraine-related disability in
patients referred to a specialty headache clinic focusing on psychiatric
comorbidity and personality characteristics.
Results Two hundred and thirty-three consecutive patients, suffering
from migraine without aura, were evaluated using MIDAS, BDI for
depression symptoms, STAI – T and STAS – T for trait anxiety and
anger, TAS – 20 for alexithymia and SCID-I for the categorical diag-
nosis of axis I psychiatric disorders. Multiple regression analysis
showed that disability was higher in those patients experiencing a high-
er number of headache days per month, more severe pain intensity,
more severe depressive symptoms, and more prolonged migraine
attacks. Other independent predictors of the total MIDAS score were
female gender and having a full-time employment. The model was
highly significant (F=18.96, p<0.00001) and explained 35% of the
observed variance (adjusted R2).
Conclusions Our findings demonstrate that, with the exception of
depression symptoms, psychiatric comorbidity has a limited influence
in modulating the impact on everyday functioning.
ACCOMPANYING SYMPTOMS AND PSYCHIATRIC
COMORBIDITY IN MIGRAINE AND TENSION-TYPE
HEADACHE PATIENTS
1F. Mongini, 1E. Rota, 1A. Deregibus, 2G. Migliaretti, 1T. Mongini, 
1L. Ferrero, 1A. Novello
1Unit of Headache-Facial Pain, Department of Clinical Patho-
physiology, University of Turin, Turin, Italy; 2Department of Public
Health and Microbiology, University of Turin, Turin, Italy; 
e-mail: franco.mongini@unito.it
Introduction It is well known that headache is frequently accompa-
nied by physical and psychiatric complaints. The association between
headache and psychiatric disorders has been extensively explored, the
most common being anxiety and depression, as demonstrated by epi-
demiological and prospective studies. The aim of this study was to
assess in patients with migraine and both episodic and chronic tension-
type headache the prevalence of accompanying symptoms and their
relationship with depression and anxiety. 
Patients and methods A psychological assessment (Axis I, DSM-IV)
was performed and 21 accompanying symptoms were investigated in
506 patients with: episodic migraine (EM, n=231), chronic migraine
(CM, n=102), episodic tension-type headache (ETTH, n=83) and
chronic tension-type headache (CTTH, n=90). The following issues
were analysed: differences in number of symptoms among the groups
and in patients with and without psychiatric comorbidity (respectively,
by means of the Kruskal-Wallis test and the Mann-Whitney Rank Sum
Test); relationship between symptoms and headache type (by means of
a Discriminant Analysis and a Logistic Regression Model); and asso-
ciation between symptoms and psychiatric comorbidity (by means of
the Fisher Exact Test). 
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Results Among the groups, the mean number of symptoms did not dif-
fer significantly, but it was significantly higher in patients with psychi-
atric comorbidity. The following associations were found: tinnitus,
cramps with EM; back pain with ETTH; vaginism/frigidity, circulato-
ry disorders and nail/hair fragility with CM; and oral parafunctions
with CTTH. Psychiatric comorbidity was significantly associated with
most of the symptoms, especially in EM.
Discussion Our results confirm that in a large and homogeneous cohort
of patients with migraine and both episodic and chronic tension-type
headache, a remarkable number of accompanying symptoms, most of
them psychosomatic in nature, are frequently reported. The finding of a
significant association between depression and/or anxiety and most of the
symptoms clearly suggests that, in migraine patients, psychiatric comor-
bidity may consistently affect the burden of accompanying symptoms. 
Conclusions In conclusion, depression and anxiety in headache
patients and particularly in EM, play a significant role in the expression
of physical complaints, whose increased burden could represent a fac-
tor by which psychiatric disorders may influence the migraine history,
thus facilitating its chronicity. This is also relevant for correctly plan-
ning treatment strategies.
COGNITIVE FUNCTIONING IN SIDE-LOCKED AND SIDE-
SHIFTING MIGRAINE PATIENTS
D. Cologno, M.G. Buzzi G.A. Carlesimo, P. Cicinelli, A. Costa, 
L. Fadda, B. Marconi, S. Pero, C. Caltagirone
I.R.C.C.S. S. Lucia Foundation, Rome, Italy; e-mail: danielacologno@
virgilio.it
Introduction One of the main features of migraine is represented by
the unilateral location of pain during attacks. Nevertheless, the data
regarding the constancy and the frequency of the unilateral location of
pain suggest that only 20% of patients report unilateral pain persisting
for the whole attack, thus, a side-locked location is infrequent. There is
little evidence regarding cognitive functioning in migraine patients.
Namely, possible differences in the cognitive profile between
migraineurs with right and left side-locked pain have rarely been
explored. The aim of the present study was to investigate the relation-
ship between the unilateral pain (with or without side-shifting) and
neuropsychological assessment in patients with migraine.
Patients and methods We recruited 35 patients (28 females and 7
males) (mean age 38.0 years, range 20–56; mean disease duration 18.5
years, range 1–37) affected by migraine without aura (MO) (n=30),
migraine with aura (MA) (n=2), or both MA and MO (n=3) with uni-
lateral pain during attacks. Patients were not receiving preventive treat-
ment and had a monthly frequency of 2–8 attacks over the 12-month
period preceding the evaluation. Neuropsychological assessment was
obtained using 24 standard tests and a computerized task to investigate
verbal and visual-spatial short-term and long-term memory, executive
functions, visual-spatial and language abilities, abstract reasoning and
attention processes. Patients were divided into 3 groups according to
the location of pain: right side-locked patients (n=17), left side-locked
patients (n=11), and right-left side-shifting patients (n=7).
Results No statistically significant differences were found in neu-
ropsychological test scores among groups (One-way ANOVA; all
p>0.10). Moreover, no correlations were found between cognitive
tasks and any of the clinical features (i.e. age at onset of migraine,
mean disease duration, and mean attack frequency) (p>0.10).
Conclusions In conclusion, our preliminary data suggest that neu-
ropsychological performances in migraine patients seem to be not
related to the side of pain, although strictly unilateral.
DIAGNOSTIC CRITERIA OF TENSION-TYPE HEADACHE
A. Forabosco, F. Vecci, T. Grandi, S. Superbi
University of Modena and Reggio Emilia, School of Dentistry,
Modena, Italy; e-mail: forabosco.andrea@unimo.it
Introduction The ”tension-type headache” is one of the most common
forms of headache: it has a lifetime prevalence of 69%  in males and
88% in females [1]. At present, the treatment for patients who suffer
from these disorders has increasingly required the need of a collabora-
tive team approach. The differential diagnosis is based on clinical cri-
teria regarding quality, localisation, and pain duration as well as lack of
autonomic symptoms.
Materials and methods According to the International Classification
of Headache Disorders, (ICHD-II), “tension headache” belongs to the
“primary headache” forms and is distinguished according to the fre-
quency of attacks in “episodic sporadic headache” (EsTTH); “episod-
ic frequent” (EfTTH) or “chronic” (CTTH). A common characteristic
of the three forms is the frequent connection with tension and/or pain
of the cranio-cervico-mandibular muscles, which is often related to
hypertrophy, dysfunctions, dental abrasion, mandibular movement lim-
itation or dental malocclusion [2]. It is very important to identify and
correctly diagnose possible dental elements involved in the field of
headache disorders in order to begin correct therapy. To attain this goal,
our team prepared a specific protocol including medical history, clini-
cal and instrumental examinations.
All the patients underwent clinical examination in two phases by the
same examiner:
- Extra-oral examination included recordings of pain in the jaw,
temples, face, preauricular area or inside the ear, at rest or during
activity, combined with tenderness on palpation of the masseter,
anterior temporalis, sternocleidomastoid, and anterior digastric
muscles.
- Intra-oral examination focused on health and dental failure, dental
mobility, occlusion according to Angle’s classification, transversal,
vertical or anteroposterior malocclusion, even with interference or
alteration of mandibular movement.
Physical tests were performed, such as the “provocation test”, the
“end-feel test”, or the “dynamic or static test”, which can indicate dif-
ferences between muscle or joint disorders [3]. To formulate a correct
diagnosis, other helpful supplementary investigations should be used,
such as radiological examination (OPT, condylar radiography, magnet-
ic resonance imaging of TMJ, CT) and instrumental examinations
(superficial electromyography, cinematic analysis and T-SCAN).
Electromyography is used as a method of investigating muscle activi-
ty at rest and during function.
Discussion and conclusions Stomatognathic system disorders may be
an important factor in the aetiology or symptomatology of tension-type
headache, which is often connected to psychological or pathophysio-
logical factors of the patients, encouraging the resolution or the dura-
tion of the disorder. It is evident how the cooperation between special-
ists of different medical fields is essential for establishing an efficient
therapy and a satisfactory remission of the disorder’s symptomatology.
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Michail Bulgakov (1891–1940) is considered one of the major
Russian contemporary authors. He graduated in medicine but left the
medical profession three years later, after the publication of his first
work in a local journal. His masterpiece, “The Master and
Margarita”, published posthumously, is structured in different levels,
apparently disconnected, but flowing into a unique design, that sees
the eternal opposition between good and evil. Part of the tale takes
place in the palace of the Roman governor of Palestine, Pontius
Pilate; despite a terrible headache, he has to judge a young Jew,
Jeshua Hanozri, condemned to death by the Synedrion. The governor
is aware of the beginning of his headache, because it starts with an
intolerance to a particular odour, the smell of rose oil. Furthermore,
it is possible to note the typical symptoms of the migraine attack from
the behaviour of the governor during the trial: photophobia, phono-
phobia, aggravation with routine physical activity, instinctive
manoeuvres to alleviate the pain intensity, and effort to maintain an
acceptable concentration. It is possible that Bulgakov, during the
years he worked as a physician, directly saw a migraine attack, and
that the description of Pontius Pilate’s migraine is a consequence of
his medical experience. However, some specifics should be given in
such detailed manner only by a migraineur: the osmophobia (not yet
inserted in the present IHS diagnostic criteria), the instinctive
manoeuvres, and the incapacitating intensity of pain. The rich details
that Bulgakov includes in the description of Pilate’s migraine,
besides being an elegant literary description of this ailment, should
be considered as evidence that he suffered from migraine.
CLINICAL OUTCOME OF HYPNIC HEADACHE
1C. Lisotto, 2F. Mainardi, 3F. Maggioni, 3G. Zanchin
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Neurologic Division, Hospital of Venice, Venice, Italy; 3Headache
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Introduction Hypnic headache (HH) is a primary headache, which
occurs exclusively during sleep. At the time of this writing, 87 patients
with this disorder have been described. The natural history of HH is not
well known. It is assumed that it tends to be chronic unremitting, but
only 25 patients have been observed for at least 2 years. To better com-
prehend the outcome of HH, we have prospectively followed 7 patients
for a period ranging from 2 to 6 years.
Results We diagnosed 7 patients (6 females and 1 male) with HH. Case
1: 76-year-old female, the headache started in 1998 and was chronic
from the onset. She died in 2004, due to cerebral haemorrhage. Case 2:
72-year-old male with a previous history of migraine, the nocturnal
headaches began in 1996 and had an episodic pattern, with two differ-
ent active periods until now, each period lasting about 6 months. Case
3: 66-year-old female with a long history of migraine, the nocturnal
attacks started in1999 and occurred in bouts of 2–3 months with inter-
vening spontaneous breaks of 4–5 months. Case 4: 74-year-old female,
the headache began in 2000 and was chronic from the onset. Case 5:
67-year-old female with previous migraine headaches, the attacks start-
ed in 2000 and remained chronic on a nightly basis over the following
years. Case 6: 64-year-old female, affected by chronic migraine. In
2003, she had a prolonged period lasting 8 months of nocturnal
headaches fulfilling the International Headache Society (IHS) criteria
for HH. During the active period of HH, she did not report migraine
attacks, which recurred with the previous usual characteristics when
the HH spontaneously ceased. Case 7: 53-year-old female, suffering
from chronic migraine. In 2003, she had a protracted period of exclu-
sively nocturnal headaches, meeting the IHS criteria for HH, with con-
current disappearance of migraine attacks. This period lasted for 4
months, then the HH attacks spontaneously disappeared and the
migraine headaches relapsed with the same previous clinical features.
Discussion Four of the seven patients with HH showed an episodic
pattern, with active periods followed by complete remissions; two
patients had only a single bout until now. In 5 patients, HH was strict-
ly associated with migraine; in 3 cases, there was a history of previous
migraine headaches, and in the remaining two patients, a bout of HH
intervened in the course of chronic migraine, with concurrent, tempo-
rary, complete remission of migraine attacks.
MIGRALEPSY: A CASE REPORT
1F. Maggioni, 1C. Perin, 1E. Mampreso, 1F. Dainese, 2C. Lisotto, 
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Migraine and epilepsy are two paroxysmal disorders with epidemio-
logical and clinical comorbidity. The mechanisms underlying this
association are not clear; it is hypothesized that the occipital cortex
in migraineurs has a low excitation threshold, which may trigger the
seizures. In addition, during migraine with aura, there are changes in
cerebral perfusion that could trigger subsequent seizures. Whereas
migraine-type headache is not uncommon following a seizure, a
seizure only rarely hits during or after a migraine attack. This phe-
nomenon, defined as “migralepsy”, has been described in subjects
affected by migraine with aura, and the diagnostic criteria have been
incorporated in the ICHD-II 2004. We report a 36-year-old female
patient with congenital hypoxic encephalopathy and repeated
episodes of migraine with aura with associated seizures (migralep-
sy). The patient was the first child, born prematurely (8th month) for
dystocia by forceps delivery. The first generalized convulsive
seizure occurred at 3-years of age. Psycho-physical development
was normal, she is married with one child, and works at a news
stand. She underwent antiepileptic therapy with phenobarbital for
occasional seizures until age 10 with no additional seizures.
Thereafter, at age 31, she experienced a visual deficit in the left
hemifield (“I saw a top spinning”), which resolved in about 20 min-
utes and was followed by a diffuse headache, pulsating, particularly
severe, associated with nausea and vomiting, and exacerbated by
physical activity. After about an hour, the patient suddenly lost con-
sciousness and fell to the ground, with clonic spasms involving all
limbs. The patient was brought to the Emergency Department where
another generalized tonic-clonic seizure occurred. Routine laborato-
ry testing, ECG, and chest X-rays were all normal. Brain-MRI
revealed a picture compatible with perinatal hypoxic damage. The
EEG showed modest signs of irritative alterations in the right tem-
poral lobe. Valproate 600 mg/day was prescribed. Since then, she
has presented 5 similar episodes of migraine with aura, followed by
secondarily generalized seizures beginning as focal motor manifes-
tations on the left side. Migralepsy disappeared (follow-up at 9
months) by increasing valproate to 1800 mg/day and adding leve-
tiracetam 1000 mg/day. Migralepsy is a rare phenomenon. Two cases
have been described with reversible MRI abnormalities during the
crisis, which suggests an inherent overlap in the underlying patho-
physiology of these events.
AMAUROSIS AND HEADACHE AS THE FIRST CLINICAL
EVIDENCE OF MULTIPLE SCLEROSIS
1F. Consolo, 1G. Santangelo, 1E. Trapolino, 1D. Bona, 1D. Buffa, 
1F. Vanadia, 2V. Raieli
1Division of Child Neuropsychiatry, “Di Cristina” Hospital, Palermo,
Italy; 2Division of Child Neuropsychiatry, “Ingrassia” Hospital,
Palermo, Italy; e-mail: flaviaconsolo@inwind.it
A 13-year-old patient presenting with amaurosis and headache was
shown by neuroimaging to have demyelinating lesions in the brain.
This case offers the opportunity to consider rare causes of secondary
headache presenting only with clinical features of migraine with aura. 
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A CASE OF HEADACHE THAT HAS TO BE DEFINED
V. Firetto, R. Fabbracci, M. Falzarano, C.A. Caputi
Pain and Palliative Care Unit, Department of Medical and Surgical
Neurological Sciences, Riuniti University Hospital, Ancona, Italy; 
e-mail: med.dolore@ao-umbertoprimo.marche.it
Introduction Precise official indications exist to aid us in headache
diagnosis. Despite the existence of the IHS classification, several cases
often cannot be classified into precise nosological entities, either due to
the variability of signs and symptoms or to therapeutic efficacy.
Case report We describe the case of an 87-year-old woman, who suf-
fered from an intolerable headache, which was located in the left
supraorbital region. During 4 months of observation, its location
remained constant, but its characteristics and associated signs instead
changed. The onset was unexpected and coincided with the position-
ing of a dental prosthesis in the left upper dental arch. Pain was pre-
ceded by cutaneous reddening, without pruritus, in the left orbital area
accompanied by prominent lacrimation of the ipsilateral eye. The
prickly and stabbing pain lasted about 1 or 2 minutes every day; the
attacks occurred, at a  set time (2 and 9 pm), with a frequency of 30
to 40 per day. After a few days of medical therapy (amitriptyline), the
frequency and form of the crises changed: a 3-hour persistent, stab-
bing and burning pain alternated with transitory crises lasting 30 min-
utes without autonomic features. After medical therapy with
amitriptyline had been suspended for excessive sleepiness, a week of
well-being followed; afterwards, 2 crises of lancinating pain, lasting
120 minutes, occurred 4 days apart and were treated with
indomethacin, prochlorperazine, and caffeine. Clinically, we noticed
an ache at the epicranial emergence points of the unilateral trigeminal
nerves. The patient was given a series of anaesthetic blocks of the epi-
cranial nerves, which produced at first, the appearance of abortive cri-
sis, followed by complete and persistent remission.
Conclusions This case is a fine example of changeable characteris-
tics and various coexisting manifestations, which prevent us from
reaching a precise diagnosis (according to the present classifica-
tion). Generically, we can consider this condition a cephalalgic
form, denominated short-lasting, unilateral, neuralgiform headache
attacks with conjunctival injection and tearing (SUNCT) with pain
length and autonomic features. However, current indications regard
the response to indomethacin as a fundamental feature in the dif-
ferential diagnosis with chronic paroxysmal emicrania. Examining
our case further, we observe that some characteristics (periodic
crises during the day, fixed-sided distribution and stabbing-type
pain) are pathognomic elements of cluster headache. We cannot
identify an exact form, or even the existence of concomitant forms,
because of the various and changeable aspects which coexist in this
case. This is a further confirmation of a growing doubt: headaches
represent a world that is yet to be defined. Thus, indications used to
determine diagnoses are not realistic representations, apart from a
few exceptions.
NEW DAILY PERSISTENT HEADACHE AND PRIMARY
STABBING HEADACHE: A CASE REPORT
1F. Mainardi, 1F. Paladin, 2C. Palestini, 2G. Zanchin
1Headache Centre, Neurologic Division, Hospital of Venice, Venice,
Italy; 2Headache Centre, Department of Neurosciences, University of
Padua, Padua, Italy; e-mail: fmainardi@iol.it
New daily persistent headache (NDPH) is a new entity, included in
the revised international classification of headache disorders
(ICHD-II) among other primary headaches (chapter 4). The main
feature of this form of headache concerns its temporal pattern, which
is chronic from the onset. Data regarding epidemiology, pathophys-
iology, and treatment of NDPH available in the literature are quite
poor. Primary stabbing headache (PSH) is a well-known form of
headache, codified in chapter 4 at the first diagnostic level, fre-
quently experienced by migraine (40%) or cluster headache (30%)
patients. We present the case of a 37-year-old woman who came to
our attention complaining for four months of a dull, mild-intensity,
diffuse headache without any accompanied signs or symptoms, and
not exacerbated by physical activity. She referred with great preci-
sion the day of onset of her headache. From the beginning, the
headache presented daily and was responsive to administration of
simple analgesics. Nevertheless, the patient rarely took drugs for
treating her headache, as it was not disabling. Furthermore, she
referred the contemporary onset of head pain occurring as a series of
stabs, in the temple and parietal areas with an alternation of side,
lasting less than three seconds, recurring 2–4 times a day, and not
accompanied by any other symptom or sign; the frequency of this
pain was not regular. General and neurological examinations were
normal. A brain MRI was performed that did not show any signifi-
cant alteration. As a preventative treatment, she was prescribed
amitriptyline 30 mg/day with a gradual, net improvement of
headache frequency. To our knowledge, this is the first case of an
association between NDPH and PSH, both forms responding to pre-
ventative treatment with low dose amitriptyline.
CASE REPORTS II
THUNDERCLAP HEADACHE BY SPONTANOUS INTRACRA-
NIAL HYPOTENSION
1E. Ferrante, 2A. Savino
1Neurosciences and 2Emergency Room Department, Niguarda Cà
Granda Hospital, Milan, Italy; e-mail: enricoferrante@libero.it
Objective To demonstrate that thunderclap headache (TH) may be the
initial manifestation of spontaneous intracranial hypotension (SIH)
caused by a CSF leak [1].
Background An excruciating headache of instantaneous onset is
known as TH. A subarachnoid haemorrhage is the prototypical cause,
but other serious disorders may also present with TH, including cere-
bral venous sinus thrombosis, carotid artery dissection, and pituitary
apoplexy. We report a group of patients with TH as the initial manifes-
tation of SIH caused by CSF leak.
Design/methods We evaluated 24 patients with SIH between 1992 and
2004. Four of them (16%; 3 females and 1 male, mean age 31 years,
range 25 to 43) initially experienced an excruciating headache of
instantaneous onset. One patient was affected by Marfan’s syndrome.
Results Excruciating pain lasted from 10 seconds to a few minutes.
The pain was described as head swelling or like a hard blow to the
head, followed by gravative occipital-nuchal and frontal orthostatic
headache. Mild neck stiffness was present in 1 patient. Patients were
studied with CT, cerebral angiography (1 patient), and MRI angiogra-
phy (1 patient), all of which were unremarkable. The patients were also
examined with lumbar puncture (3 patients), brain gadolinium MRI,
spinal MRI and MRI myelography (3 patients), CT myelogram (1
patient), and radioisotope cisternography (1 patient). CSF pressure was
low. Brain MRI showed diffuse pachymeningeal enhancement in all
patients. CSF leakage was demonstrated gadolinium in only 1 patient
at the cervical level. Three patients received supportive measures only
(bed rest, analgesics, and hydration). The patient with cervical CSF
leak underwent epidural blood patch.
Conclusions We suggest that SIH should be included in the differ-
ential diagnosis of thunderclap headache even when meningism is
present.
Reference
1. Ferrante E, Savino A, Sances G, Nappi G (2004) Spontaneous
intracranial hypotension syndrome: report of twelve cases.
Headache 44:615–622
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A CASE OF CHRONIC PAROXYSMAL HEMICRANIA WORS-
ENED BY ABNORMALITIES OF STATIC CERVICAL LOAD
G. Capo
Headache Centre, Neurology Unit, “San Giovanni di Dio and Ruggi
D’Aragona” Hospital, Salerno, Italy; e-mail: afep@libero.it
We report the case of a then 50-year-old menopausal woman, who
began to complain of mild, tolerable pain at the temple and in the left
orbital and periorbital region, lasting 10–20 minutes and occurring 4–5
times a day. When she was 60-years-old, there was an intensification
of the attacks with symptoms of conjunctival injection, lacrimation and
ipsilateral rhinorrhoea, although the number and duration of the attacks
did not change. At age 62, she underwent a surgical operation to cor-
rect an S-shaped scoliosis with application of a support bar along 14
vertebral (T2 to L4). Two months before the operation, while she was
wearing a trunk plaster cast, she noticed that the occipital region ached
during the attacks. After the operation, the plaster cast was positioned
not at the base of the neck but at the base of the head. Immediately after
removal of the plaster cast, the attacks got remarkably worse; using a
scale from 1 to 10, pain intensity was 10, lasting always 10-20 minutes.
The autonomic phenomena were more remarkable, with the number of
attacks once every 2 hours during daytime, and once every 3 hours at
night (10–11 a day). NSAIDs, gabapentin, and cortisone infiltrations
had no effect. When she was 67-years-old, she was visited at our
headache centre. The neurological examination was unremarkable with
few alterations; brain CT and blood tests were not relevant; the diag-
nosis was chronic paroxysmal hemicrania [1]. She was prescribed
indomethacin 50 mg/day and for the first time in 15 years experienced
tangible improvements, with a reduction in the number of attacks to
2–4/day, mitigation of the autonomic phenomena, and reduction in the
intensity of pain from 10 to 4–5. During the following years, she con-
tinued to use indomethacin at the highest dosage of 100 mg/day with
positive effects. The relevant elements in this case are:
1. pain was extended to the cervical area when she wore a plaster cast
before the operation;
2. lack of homogeneous distribution of attacks during daytime and
nighttime [2];
3. considerable aggravation after the operation on the spinal column
and after removal of the plaster cast probably in relation to alter-
ations of the static cervical load.
References
1. Antonaci F, Sjaastad O (1989) Chronic paroxysmal hemicrania
(CPH): a review of the clinical manifestations. Headache
29:648–656
2. Pareja JA (1995) Chronic paroxysmal hemicrania (CPH): dissocia-
tion of the pain and autonomic features. Headache 35:111–113
MIGRAINE SECONDARY TO SUPERIOR OBLIQUE
MYOKYMIA RESPONSIVE TO GABAPENTIN: A CASE
REPORT
1F. Maggioni, 1F. Dainese, 1A. Campagnaro, 2F. Mainardi, 1S. Ruffatti,
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A case of migraine secondary to superior oblique myokymia (SOM) is
reported. SOM is characterized by intermittent, small-amplitude,
monocular, paroxysmal, high-frequency oscillations. These oscillations
are mainly torsional in the primary gaze position and in abduction and
evoke oscillopsia during paroxysms. The pathophysiology of this con-
dition is not clear; often the patients are otherwise healthy, sometimes
vascular compression of the IVth cranial nerve may be responsible, and
rarely there are other neurologic diseases. A 27-year-old male with a
negative clinical history, reported that four years ago he started experi-
encing a “tremor” of the left eye. The duration of the initial symptom
was 1 to 2 minutes, with periods of spontaneous remission during the
first 2 years from onset; subsequently, the attacks occurred almost daily.
The “tremor” was followed by a pulsating headache, which spread from
the back of the neck to one-half of the head, almost always on the left
side. The intensity was moderate-severe and receded after taking parac-
etamol or nimesulide orally. The frequency was about 3–4 episodes per
week and was triggered mainly in those situations in which he was
forced to concentrate. The headache never occurred during the night; it
was associated with phonophobia, photophobia, osmophobia, and if of
severe intensity, also with nausea without vomiting. The attack lasted a
few hours. The eye examination was negative. The condition was so
disabling that the patient interrupted his studies. During the years he
underwent routine blood tests, ECG, EEG, VEP and BAERS, chest X-
rays, CT of the paranasal sinuses and orbits, brain MRI with gadolini-
um and angio-CT, all with negative results. The Hess-Lancaster Test
showed in the left eye hyperfunction of the superior oblique muscle
compatible with the diagnosis of SOM. Treatment with baclofen 50
mg/day, levetiracetam 1500 mg/day, bromazepam 3 mg/day, and carba-
mazepine 600 mg/day for at least 2 months was unsuccessful;
gabapentin was then started and progressively increased to 900 mg/day.
Once this dosage was reached the myokymia receded, and the patient
had no other migraine attacks. Follow-up visits at 3, 6, and 9 months
were negative for myokymia and headache. The correlation between
the two pathologies is substantiated by the clinical trend of the disorder
and by the resolution of the attacks with an effective therapy. This case
calls attention to the correlation between migraine and SOM and pro-
poses gabapentin for treatment of this condition. 
CLINICAL AND RADIOLOGICAL FINDINGS IN A CASE OF
SYMPTOMATIC CLUSTER HEADACHE
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Introduction Cluster Headache (CH) is a primary disorder, defined by
the International Headache Society (IHS) classification as a severe uni-
lateral pain lasting 15–180 minutes if untreated and associated with
ipsilateral autonomic dysfunction and/or agitation [1]. In recent years,
several cases of cluster-like syndromes associated with intracranial
pathologies have been described, usually with atypical manifestations
[2]. We report a case of cluster-like headache completely fulfilling IHS
diagnostic criteria at the time of presentation, with neuroimaging evi-
dence of an organic brain lesion.  
Case history A 60-year-old woman presented with a 3-week history of
paroxysmal headaches occurring every night at the same hour (about
4:00 AM) and lasting 30 to 90 minutes. The pain was severe or excru-
ciatingly severe, strictly localised in the left temporal region, and
accompanied by ipsilateral lacrimation, conjunctival injection, rhinor-
rhoea, and occasionally, ptosis. The initial physical examination dis-
closed exclusively a mild left eyelid ptosis. The initial laboratory para-
meters and CT scan with contrast enhancement were normal. The
patient was administered prednisone 50 mg daily, with rapid and com-
plete improvement. Two weeks later, she reported intermittent diplop-
ia and the ptosis worsened. Furthermore, a few days earlier the patient
had begun suffering from low back pain. A brain MRI showed an
iso/hyperintense area in the anterior aspect of the left cavernous sinus,
significantly enhanced by contrast material, consistent with a possible
metastatic lesion. In a few days, the ptosis became complete and low
back pain worsened; the patient was subsequently admitted to the hos-
pital. The spinal X-ray and total-body CT scan disclosed the presence
of diffuse bone and liver metastases. A CT-guided liver biopsy was per-
formed and the histological examination revealed metastasis from an
undifferentiated carcinoma of unknown origin. The patient died 35
days after onset of the symptoms. An autopsy was not performed.
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Discussion Increasing evidence indicates that pain and autonomic
symptoms typical of CH result from activation of the trigeminal vas-
cular and cranial parasympathetic pathways. The circadian rhythmici-
ty of CH is thought to result from hypothalamic dysfunction, with sec-
ondary involvement of the trigeminal autonomic pathways, as demon-
strated by PET studies [3]. Our case indicates that an organic lesion in
the anterior aspect of the cavernous sinus presumably involving the
first division of the trigeminal nerve could have triggered the trigemi-
nal autonomic hypothalamic circuitry. CH is a well-defined primary
headache syndrome with a peculiar clinical picture that allows a rela-
tively easy diagnosis. Nevertheless, a cluster-like syndrome can be the
consequence of a structural brain injury involving primarily the cav-
ernous sinus and the trigeminal autonomic complex. The presence of
even minimal unusual aspects must prompt the clinician to seek a sec-
ondary cause of CH.
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FAMILIAL TRIGEMINAL NEURALGIA: CASE REPORT
V. Firetto, R. Fabbracci, M. Falzarano, C.A. Caputi
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e-mail: med.dolore@ao-umbertoprimo.marche.it
Introduction Only 20 cases of familial trigeminal neuralgia have been
described in the literature, frequently in association with glossopha-
ryngeal neuralgia, Charcot-Marie-Tooth neuropathy, or hypertension
and brachydactylia. A mechanism of autosomal dominant transmission
is assumed whose relevance still remains uncertain. 
Case report We describe the case of a 60-year-old man. Twenty-five
years ago, he suffered from paroxysmal crises of severe, burning, lan-
cinating pain in the right V1 and V2 divisions of the trigeminal nerve,
associated with trigger points and accompanied by lacrimation. The
pain was provoked by mastication and speech. The patient controlled
the symptomatology by means of medical therapy (carbamazepine),
progressively increasing the dosage because of its worsening, with no
results as yet. After diagnostic examinations excluded a secondary
cause, we decided at first to continue the medical therapy (carba-
mazepine+gabapentin), which initially resulted in a partial resolution
of the crises in the territory of the first trigeminal branch. Subsequently,
we decided to subject the patient to radiofrequency coagulation of the
Gasser ganglion, which had a positive outcome. During the taking of
the patient’s history, we also found the presence of trigeminal neural-
gia in the other two brothers. One of his brothers, 70-years-old, also
had his first attack when he was approximately 30-years-old, and jolts
always interested the same territory of distribution (right V1 and V2
divisions); he underwent alcohol block of the Gasser ganglion 20 years
ago, with only 4 months of complete anaesthesia. Currently, he is in
pharmacological therapy (carbamazepine) with good control of the
symptomatology. The other brother, 64-years-old, had the first attack
only 2 years ago, in the same territory of distribution of the trigeminal
nerve (right V1 and V2 divisions). Pharmacological therapy
(gabapentin) manages to control the symptomatology. The interesting
feature is that 40-years ago, he was diagnosed with a form of multiple
sclerosis, which is recognized to be one of the causes of secondary
trigeminal neuralgia.
Conclusions We believe that the clinical history of the first two broth-
ers can be considered an example of rare familial trigeminal neuralgia;
conversely, the third case has to be included in a secondary form of
trigeminal neuralgia (connected with multiple sclerosis). However, we
emphasize that multiple sclerosis is a genetic disease. In our opinion,
this case is interesting as it can confirm a pathogenetic hypothesis of
familial trigeminal neuralgia (autosomal dominant) and, moreover, it
suggests the necessity of further studies on penetrance and genetic
localization, in order to understand what factors determine predisposi-
tion to the development of cranial neuralgias among the same familial
nucleus, without stopping at the appeared coincidence of two familial
forms and a secondary one among three brothers.  
UNUSUAL HEADACHE: THE ONSET SYMPTOM OF ONE
CASE OF SPONTANEOUS SPINAL EPIDURAL HEMATOMA
1A. Giorgetti, 2M. Conti
1Neurology Unit, Legnano Civil Hospital, Legnano, Italy;
2Neurosurgery Unit, Legnano Civil Hospital, Legnano, Italy; 
e-mail: giorgettiandrea@aliceposta.it
Spontaneous spinal epidural hematoma (SSEH) is a rare clinical entity
[1] and represents a neurosurgical emergency requiring urgent investi-
gation and prompt intervention. We describe one case of SSEH admit-
ted to our department: a 77-year-old woman presented with an intense
and incapacitating headache resembling the one attributed to subarach-
noid haemorrhage immediately followed by sensory and motor dys-
function. Magnetic resonance imaging (MRI) of the cervical spine
revealed a C2-C4 dorsally placed extradural lesion causing significant
compression on the thecal sac. A partial C2-C4 and complete C3 hemi-
laminectomy on the left side was performed. No abnormal vessels were
noted during surgery. The patient made an almost complete recovery of
the deficits within a week. Although our case was initially suspected as
cerebral stroke, a MRI of the cervical spine was performed on the spine
and spinal cord in the axial and sagittal sections. SSEH should be sus-
pected in the differential diagnosis of sudden, intense headache and
neck pain with radicular radiation, accompanied by variable neurolog-
ical deficits, and when confirmed by MRI, emergent surgical decom-
pression should be performed. Early diagnosis and immediate treat-
ment are mandatory to obtain good prognosis for patients with SSEH
[2]. In most cases, such as ours, emergent surgical treatment leads to
complete resolution of the symptoms.
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HEADACHE IN CHILDHOOD AND ADOLESCENCE I
PRIMARY HEADACHE AMONG ADOLESCENTS: CLINICAL
CHARACTERISTICS AND PSYCHOSOCIAL CORRELATES
F. Pistoia, T. Russo, S. Sacco, A. Carolei, C. Marini
Department of Neurology, University of L’Aquila, L’Aquila, Italy; 
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Objective Headache is a common problem among children in primary
school. We evaluated the prevalence of headache subtypes in adoles-
cents, aged 14 to 15 years, in primary school, and their relationship
with lifestyle and psychological aspects.
Subjects and methods The study population was screened with a mul-
tistage questionnaire between May and June 2004, in 4 primary schools
of L’Aquila. Data were collected by means of a screening question-
naire, consisting of 31 items, administered to all students; a clinical
interview, based on 33 questions; and the Migraine Disability
Assessment Scale (MIDAS), administered to all headache sufferers.
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Headache was diagnosed according to the diagnostic criteria of the
International Headache Society, 2nd edition. Students without
headache were used as controls.
Results Among a total of 151 students examined, 52 (34.4%; 95% CI
26.9–42.0) reported recurrent headache episodes (6 men and 46
women, mean age 15±0.6 years). Migraine without aura (IHS 1.1) was
the most frequent diagnosis (50%), followed by probable migraine
with or without aura (IHS 1.6) (17.3%), frequent episodic tension-type
headache (IHS 2.2) (13.5%), infrequent episodic tension-type
headache (IHS 2.1) (7.7%), chronic tension-type headache (IHS 2.3)
(3.8%), migraine with aura (IHS 1.2) (3.8%), probable tension-type
headache (IHS 2.4) (1.9%), and unspecified headache (IHS 14.2)
(1.9%). Emotional disorders were more frequently reported by
headache sufferers compared with control subjects: anxiety feelings
were mostly associated with tension-type headache (OR=12.6; 95% CI
2.3–67.4), whereas mood disorders were mainly observed among
patients with migraine (OR=5.4; 95% CI 2.1–14.0). Insomnia was
more frequent in subjects with migraine (OR=2.8; 95% CI 1.1–7.4). A
trend towards an increased time spent watching TV was found in
patients with tension-type headache (OR=4.3; 95% CI 1.2–15.2).
Conclusions Headache is frequent among adolescents and is mainly
related to psychological comorbidity and lifestyle. Assessing headache
among adolescents as early as possible is essential in order to plan ade-
quate preventive strategies.
* The study was supported by the local section of the Italian
Association in the Fight against Headaches (AIC – ONLUS).
CLINICAL STUDY AND FOLLOW-UP IN PRESCHOOL AGE
CHILDREN SUFFERING FROM PRIMARY HEADACHE
1P.A. Battistella, 2E. Fiumana, 1M. Binelli, 1E. Bertossi, 1P. Battista, 
1E. Perakis, 2S. Soriani
1Department of Paediatrics, University of Padua, Padua, Italy; 2Clinic
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Introduction In preschool children, the prevalence of headache ranges
from 3% to 6% and migraine from 3% to 7.4%; moreover, 25% of
migraineurs have their first attack in the preschool period. Goals of this
study were to compare two different paediatric age groups of headache
sufferers and to evaluate the existence of predictive factors.
Subjects and methods Two groups of subjects were considered: the
first group (G1) with early headache onset (<6 years old) and the sec-
ond (G2) with late onset (12–18 years old). The diagnosis was made
according to the IHS 1988 criteria (retrospective study).
Results G1 consisted of 163 subjects, mean age at first evaluation
4.9±0.9 years (range 2–16) and mean age at headache onset 3.8±1.0
years (range 1–5.8), and G2 consisted of 80 subjects, age at first eval-
uation 14.4±1.4 years (range 12–18) and mean age at headache onset
13.1±1.2 years (range 12–16.5). The male percentage was higher in G1
(58%) than in G2 (39%). The attacks lasted less than 1 hour in 52% of
G1 and 15% of G2. Associated symptoms prevailed in G2: nausea
(39% vs. 20%), photophobia (70% vs. 52%) and phonophobia (72% vs.
54%), while vomiting was similar (19% vs. 18%). In G1 compared to
G2, the diagnosis of migraine (M) was made in 36% vs. 58%, tension-
type headache (TTH) in 42% vs. 41%, and idiopathic stabbing
headache (ISH) in 10% vs. 1%. In G1, 12% were not classifiable (0%
in G2). The diagnosis of migraine disorder 1.7 prevailed in G1 (54%)
vs. G2 (22%) as well as tension-type disorder 2.3 (51% vs. 39%).
Family history of headache prevailed in G1 (78%) vs. G2 (59%). The
mean follow-up of G1 was 3.5±2.7 years (range 0.5–10). The first
diagnosis remained the same for 61% of M and 46% of TTH. None of
the subjects with episodic TTH became chronic, while 50% of those
with chronic TTH became episodic. The prognosis was: remission
(21%), improvement (46%), worsening (15%), and stability (18%).
Favourable evaluation was superior in TTH and ISH compared to M.
Unfavourable outcome was associated with vomiting during attacks.
Discussion This study shows different gender distribution in the two
groups as reported in the literature. Our data suggest that preschool age
headache has different clinical characteristics. Positive family history
represents an additional risk factor for young patients, especially for
M. In our follow-up, headache with preschool age onset seems to have
a relatively benign prognosis. 
OSMOPHOBIA IN JUVENILE PRIMARY HEADACHES
1E. Corletto, 1P.A. Battistella, 2F. Dainese, 1L. Dal Zotto, 2F. Maggioni,
1A. Resos, 2G. Zanchin
Department of Paediatrics, University of Padua, Padua, Italy;
2Headache Centre, Department of Neurosciences, University of Padua,
Padua, Italy; e-mail: battist@pediatria.unipd.it
Introduction The differential diagnosis between migraine (M) and
tension-type headache (TTH) is based on ICHD-II criteria (2004),
among which the associated symptoms of nausea, vomiting, photo- and
phonophobia are very important. Osmophobia (O), commonly
described during migraine attacks and reported in the “Appendix” of
ICHD-II as a possible accompanying symptom of migraine without
aura (MO), has never been studied in childhood headache. The aims of
the study were: to evaluate the prevalence of O in juvenile primary
headache sufferers in M versus TTH patients; to analyse which attack
phase is most frequently associated with O; to verify possible correla-
tions with gender and/or age; to identify the prevailing types of offend-
ing stimuli; and to assess whether and which odours might trigger
attacks.
Patients and methods We recruited 123 consecutive outpatients
referred to the Childhood and Adolescent Centre for Headaches in 2005,
mean age of 11.1 years (range 6–18 years), 74 females and 49 males.
According to ICHD-II criteria, M was diagnosed in 69 patients (56%;
MO 60, MA 9), and TTH in 54 patients (44%; ETTH 46, CTTH 8).
Results Prevalence: during the attacks, 18.7% of headache patients
reported O. Gender: O was reported by 65.2% of females and 34.8% of
males. Age was uncorrelated with O. Type of headache: O was more
frequent in M (21.7%) than in TTH patients (14.9%). Specifically, O
was prevalent among male M sufferers (26.9% vs. 18.6%), and female
TTH patients (20% vs. 5.3%). The other associated symptoms were:
nausea (34.1%; M patients, 78.3% vs. TTH, 3.7%); vomiting (17.8%;
M patients, 31.9%); photophobia (63.4%; M patients, 78.3% vs. TTH,
44.4%); phonophobia (61%; M patients, 68.1% vs. TTH, 51.8%).
Among osmophobic patients, 74.0% reported O during the attack and
26% prior. The offending odours were perfumes (56.5%), food-related
smells (47.8%), smoke (34.8%), and other odours (4.3%). The olfacto-
ry stimulus triggered the attack in 43.5% of osmophobic patients, that
is, in 8.1% of the entire study population (MO, MA, TTH).
Discussion Our preliminary results indicate that O is present during
headache attack also in juvenile primary headaches, particularly in
migraineurs, but it seems less specific than in adults. The main offend-
ing odour is perfume.
HEADACHE RECURRENCE IN FAMILY AND CLINICAL
CHARACTERISTICS: A CLINICAL STUDY ON 200 CHIL-
DREN AND ADOLESCENTS
L. Canzano, F. Galli, V. Guidetti
Department of Child and Adolescent Neurology, Psychiatry and
Rehabilitation, University La Sapienza, Rome, Italy; e-mail: 
federica.g@uniroma1.it
Introduction Migraine is a complex disease, where genetics and biol-
ogy interact with environmental factors, determining a polygenic mul-
tifactorial etiology. 
Objective The aim of this study was to analyse whether the clinical
characteristics of migraine change according to headache familial
recurrence compared with other Headache subtypes (oHs).
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Subjects and methods Two hundred children (92 M; 108 F; range
4.6–17.9 years) and their parents were enrolled in the study. To record
headache history and symptomatology, a semistructured interview
(ICHD-II criteria 2004) was carried out. Data were collected on the
occurrence of headache in first and (indirectly) second-degree rela-
tives. Chi-square was computed to analyse contingency tables. 
Results Cross-checking data on the family history of migraine and
oHs, we found that 138 patients (69%) were positive for migraine.
Thirty-eight children had no positive family history of either migraine
or oHs (19%), whereas 93 children had one parent diagnosed with
either migraine or oHs (46.5%) and 69 children had both parents diag-
nosed with either migraine or oHs (34.5%). Prevalence of headache of
any kind in parents was 81%, with a predominance in the family of
migraineurs. Twenty-two patients did not have any parents with
headache (11% vs. 8% oHs); 42 had only the mother (21% vs. 8%
oHs); 25 only the father (12.5% vs. 5% oHs); and 49 had both parents
(24.5% vs. 10% oHs). The clinical characteristics and age at onset of
migraine were not influenced by the presence of headache in parents,
but considering second-degree relatives (double familial loading), dif-
ferences in headache characteristics were found: aura and photophobia
(p<0.05). 
Discussion The recurrence of headache in family members strongly
suggests a genetic transmission of headache. However, this kind of
transmission was studied extensively in migraineurs, even though one
study [1] showed a 3.1-fold increased risk of chronic tension-type
headache among first-degree relatives of probands with chronic ten-
sion-type headache. Our findings underscore the importance of genet-
ic factors (mostly in the maternal line) in migraine, but less for tension-
type headache. No difference in clinical phenotype exists in migraine
according to familial occurrence, except for aura and photophobia, if
double familial loading was considered.
Conclusions Children with migraine have more often first and second-
degree relatives with migraine (mainly in the maternal line). Only the
symptoms of photophobia and aura seem to show the effect of a likely
genetic-related transmission.
Reference
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THE COLD PRESSOR TEST: COMPARISON BETWEEN
CHILDREN WITH HEADACHE AND THEIR HEALTHY PEERS
M. Trapanotto, D. Gobber, F. Benini, G. Pozziani, S. Barbieri, 
P.A. Battistella
Department of Paediatrics, University of Padua, Padua, Italy; e-mail:
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Introduction Few studies have investigated experimentally-induced
pain perception in children with chronic painful symptoms, especially
psychophysiological reactivity. This type of research may elucidate
certain mechanisms occurring in chronically painful conditions [1, 2].
The aim of this study was to assess reactivity to pain induced with the
cold pressor test - turning to subjective, behavioural and physiological
parameters - in a group of headache children compared with healthy
children.
Patients and methods Thirty-two patients affected by recurrent pri-
mary headache (15 M, 17 F) (18 with migraine without aura (MO); 14
with chronic tension-type headache (CTTH)) (mean age 10.6 years; SD
1.6), for over 6 months, were compared with the sample of 141 healthy
children (77 M, 64 F) (mean age 10.1 years; SD 1.24). In this study a
new instrument, validated in a previous research, was used to induce
cold pressor pain.
Procedure The child was asked to immerse the arm in water at ambi-
ent temperature (Baseline) and a Visual Analogue Scale and Face Scale
were administered. After 2 minutes, the child was asked to put the arm
into the tank containing cold water at 10°C (Start) and to report the first
pain sensation (Threshold) and intolerable pain (Tolerance). Between
these two stages, at 10-second intervals, the child assessed the pain on
a scale of 0-10. At the end of pain induction (max 3 minutes), the child
again placed the arm in the first tank and repeated the subjective scales
(Recovery). During the test, the cardiovascular indexes were recorded
continuously and the pressor indexes were measured three times.
Results The mean age of headache children was slightly higher than
that of healthy children. The latency times for the pain threshold were
comparable in the two groups, whereas the pain tolerance was higher
in the headache sufferers. The sensorial and affective assessments, like
the trend of the pain, were comparable in the groups. During the
painful stimulation, an increase in all the cardiovascular indexes - with
the exception of the resistances which diminished – was observed.
Although no statistically significant differences emerged, the mean
stroke volume values and peripheral resistances tended to be higher in
the headache sufferers. The headache characteristics did not influence
the children’s pain perception.
Conclusions Apart from a greater pain tolerance, reactivity to pain in
patients with recurrent headache seems to be much the same as in
healthy children. Physiological indicators follow the same trend in the
two groups, although minor differences might suggest a hyperfunc-
tioning of the sympathetic nervous system in the headache sufferers.
References
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HEADACHE IN CHILDHOOD AND ADOLESCENCE II
THE IMPACT OF LIFE EVENTS ON PRIMARY HEADACHE
IN CHILDREN AND ADOLESCENTS
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Introduction The relevance of psychological factors as triggers of
headache disorders has been extensively outlined, but often without
making clear distinction between the occurrence of life events, psychi-
atric comorbidity, or psychosocial factors. The association between
different headache subtypes and the direction of influence between
psychological factors and headache is a matter of debate. The aim of
this study was to analyse the occurrence of major life events in differ-
ent headache sub-types.
Subjects and methods To record headache history and symptomatol-
ogy, we used a semistructured questionnaire with a section on history
of life events (e.g. divorce, moving, serious illnesses, etc). This ques-
tionnaire was administered to parents to collect data on 187 children
and adolescents (range 4.6-17.9 years; 89 M; 98 F) with migraine with-
out aura (MO), migraine with aura (MA), and episodic and chronic
tension-type headache (ETTH) (CTTH). Headaches were diagnosed
according to ICDH-II criteria (2004). Chi-squares were computed in
order to analyse contingency tables. 
Results Of 138 migraineurs, 30 (22%) subjects showed significant life
events (MO=23; MA=7), and of 49 tension-type headache patients, 15
(30.6%) showed the same condition (CTTH=13; ETTH=2), whereas
40.6% (13/32) of CTTH, 28% (7/25) of MA, 20.3% (23/113) of MO
and 11.7% (2/17) of ETTH patients showed significant life events
(p<0.05).
Discussion Major life events (divorced, widowed, separated) have
been related to headache chronicity in adults [1]. Karwautz et al. [2]
showed that migraine was not related to psychosocial factors, whereas
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TTH was associated with a higher rate of divorced parents and fewer
peer relations. Our findings confirmed the recurrence of life events
both in CTTH and MA (the severest headache sub-types for recurrence
and intensity rates), independently from likely genetic factors (more
related to MA).
Conclusions This study shows an important link between major life
events and headaches, which points toward the relationship between
headache and psychological factors.
References
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PSYCHIATRIC COMORBIDITY AND PRIMARY HEADACHE
IN CHILDREN AND ADOLESCENTS: A CLINICAL STUDY ON
FAMILIAL RECURRENCE
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Introduction The relevance of psychiatric comorbidity (Psi-co) in
headache raises questions on the likelihood of a common etiological
mechanism and direction of influence.
Objective Our aim was to analyse the relationship between familial
recurrence of headache and psychiatric disorders by estimating the
prevalence of mood, sleep and anxiety disorders in children compared
with their parents’ Psi-co and headache.
Patients and methods Headache history and symptomatology were
collected in a clinical sample of 200 patients and their families, using
a semistructured questionnaire (ICHD-II criteria, 2004). The question-
naire was composed of different sections in which we assessed Psi-co
in parents, according to DSM-IV criteria. Chi-square was calculated to
analyse contingency tables. 
Results One hundred and twenty-three patients (61.5%) referred psy-
chiatric disorders: 77 (38.5%) sleep disorders, 89 (44.5%) anxiety dis-
orders, and 6 (3%) mood disorders (multiple disorders co-occurred in
23% of patients). Comparing psychiatric comorbidity and different
diagnosis: 71 (62.8%) migraine without aura (MO) and 16 (64%)
migraine with aura (MA) children had psychiatric disorders, versus 20
(62.5%) chronic tension-type headache (CTTH), and 10 (58.8%)
episodic tension-type headache (ETTH) patients (n.s.). Analysis of Psi-
co showed that 94 mothers (47%) and 51 fathers (25.5%) had at least
one psychiatric disorder (mainly mood and anxiety disorders), while
analysis of headache diagnoses in children (migraine) revealed a signif-
icantly statistical relation when comparing migraineurs versus non-
migraineurs: parents of children with migraine showed higher levels of
maternal Psi-co, (p<0.05). It is worthy to note, that patients of mothers
with Psi-co showed higher recurrence of psychiatric disorders than chil-
dren whose mothers had no history of psychiatric disorders: 65 (69.1%)
vs. 29 (30.9%) (p<0.05), without differences across headache subtypes.
Children suffering from multiple psychiatric disorders had more often
mothers with psychiatric disorders than those children whose mothers
had no history of psychiatric disorders (Chi2=4.382; gdl=1; p=0.036).
By considering anxiety disorders, we found that 36 of 57 children
(63%) had mothers with anxiety disorders, while of 111 children who
did not suffer from this disorder, 41 (37%) had mothers with psychiatric
disorders (mother: chi2=5.534; p=0.019; father: chi2=0.277, n.s.).
Discussion Not only migraine, but also psychiatric disorders run in
families. This finding needs to be further studied to understand the
influence and likelihood of a co-transmission of headache and psychi-
atric disorders.
Conclusions The occurrence of psychiatric disorders is high not only
in children with headaches but also in their parents and is common to
all headache subtypes, even though it is greater in migraine than in
other headache subtypes. It may be due to a genetic mechanism, but the
role of a shared familial environment needs exploration.
HEADACHE COMORBIDITY IN CHILDHOOD
E. Tozzi, M.I. Florio, E. Cicconi, R. Savini, G. Sciarone
Paediatric Clinic, University of L’Aquila, L’Aquila, Italy; e-mail:
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Introduction Headache comorbidity has been studied more in adults
than in children and adolescents. Comorbidity is very important and in
recent years has influenced diagnostic procedures and therapy.
Aim The aim of the present study was to evaluate retrospectively the
comorbidity in children to verify any differences among patients pre-
senting headache with and without comorbidity.
Patients and methods The sample consisted of 120 children, 49 males
and 61 females, who presented to the Paediatric Headache Clinic of the
University of L’Aquila in the last year (2004). Each patient completed a
questionnaire with information about the headache and personal history.
The age range was 3–14 years. The children were divided into 3 groups
according to age: Group 1, 25 children, aged 3–5 years; Group 2, 70
children, aged 6–10 years; and Group 3, 15 children, aged 10–14 years.
Results Fifty-four patients suffered from tension-type headache (TTH)
and 55 from migraine with and without aura (M). Comorbidity was
found in 71% of the sample and there were differences among the 3
groups: 60% in Group 1, 84% in Group 2, and 93% in Group 3
(p<0.01). The prevalent comorbidities were: sleep disorders (22%),
thinness (14%), epilepsy (12%), obesity (10%), fainting (6%), allergies
(12%), and psychiatric disorders (8%). There was no difference
between males and females. Epilepsy, thinness, and allergies were
prevalent in migraine patients, whereas obesity and psychiatric disor-
ders were prevalent in TTH patients (p<0.05).
Conclusions We underline the high percentage of comorbidity in ado-
lescence (Group 3). Epilepsy and obesity are factors that have an influ-
ence on the therapy of children examined.
HOW THE LOSS OF EITHER PARENT AFFECTS A CHILD’S
HEADACHE
D. Moscato, M.I. Peracchi
Childhood Headache Centre, S. Charles Hospital, Rome, Italy; e-mail:
dmoscat@tin.it
An event with strong emotional impact, such as the loss of a family
member, has often been indicated as a trigger for headache. The pur-
pose of this study was to compare the headache characteristics of a
group of patients without either parent. In 6 months, 320 patients were
evaluated, of whom 51 (15.9%) without either parent (separation,
68.8%; divorce, 23.5%; death, 7.8%). These were compared with
young headache sufferers (HS) having both parents. Headache charac-
teristics and psychiatric comorbidity were evaluated. Group I: n=51
(25 M, 26 F), age range 3–18 years; mean 11.4±2.9 years. Group II:
n=51 (24 M, 27 F), age range 3–18 years; mean 9.9±2.9 years.
Episodic tension-type headache (ETTH) and migraine without aura
(MO) were reviewed. Migraine with aura (MA) (Group I: n=29 (17 F,
12 M), M.I.(DxI) 8±2.4; Group II: n=25 (14 F, 11 M), M.I. 3.7±3.4,
p<0.0001). ETTH (Group I: n=12 (7 F, 5 M), M.I. 6±2.6; Group II:
n=22 (9 M, 13 F), M.I. 3.5±3.8, p<0.0001). In only 10% of Group I did
the onset of headache coincide with the loss of either parent (3 MA, 1
ETTH). In Group I, anxiety was higher in ETTH patients, and depres-
sion in those with MA. Headache is more evident in HS who have lost
a family figure, but is not a trigger. The high levels of anxiety and
depression show greater involvement of HS. More attention to the
child’s environment is per se a therapeutic intervention.
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MIGRAINE AND TENSION-TYPE HEADACHE IN CHILD-
HOOD AND ADOLESCENCE: IS THE PSYCHOTHERAPEUTIC
APPROACH MORE OR LESS EFFECTIVE THAN TRADITION-
AL OUTPATIENT TREATMENT? A CONTROLLED TRIAL
1M. Rossi, 2M. Racca, 2C. Termine, 2M. Ferri, 1M. Chiappedi, 
1G. Rossi, 1G. Lanzi, 2U. Balottin
1Department of Child Neurology and Psychiatry, IRCCS “C. Mondino
Foundation”, University of Pavia, Pavia, Italy; 2Child
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Introduction The management of child and adolescent idiopathic
headache currently involves psychological interventions in association
with pharmacotherapy. Despite the fact that psychological therapies are
nowadays widely used in clinical practice, yet there is a paucity of
research on their efficacy. The present study is a randomised controlled
trial evaluating the effectiveness of brief psychodynamic therapy
(BPT) in the treatment of child and adolescent idiopathic headache.
Subjects and methods Subjects aged from 6 to 18 years referring to
our outpatient service for newly diagnosed idiopathic headache were
randomly assigned to either an experimental group or a control group.
Within the experimental group, patients received a time-limited (8–10
sessions) psychodynamic therapy, held in individual or family ses-
sions, every two weeks. In contrast, the control group performed the
standard outpatient treatment, which entailed a follow-up visit every
two months after the first consultation. The two groups were evaluated
at baseline (T0) and at a 6-month follow-up after the beginning of the
study (T1). Measures of effectiveness were reduction of attack fre-
quency, duration and intensity and improvement in patients’ quality of
life and global functioning, as reported by EuroQoL, CBCL and CGI
scores. Given the small sample size, statistical analyses were per-
formed with a 1% level of significance.
Results Thirty-three subjects completed the study: 17 patients (9
males, 8 females; mean age 9.18 years; SD±2.07) were assigned to the
experimental group and 16 subjects (4 males, 12 females; mean age
10.20; SD±2.72) were allocated to the control group. Comparing the
two treatment groups at T0, there were no significant differences in the
main demographic and clinical data. At T1 the experimental group
exhibited a statistically significant reduction in the duration of
headache attacks (p=0.005) and improvement in the patients’ quality of
life, as reported by EuroQoL (p<0.001). Furthermore, T0/T1 compari-
son showed a statistically significant improvement in the CBCL
Psychosomatic Complaints scale score (p=0.01) in the experimental
group. Individual and family psychotherapeutic approaches seemed to
be equally effective.
Discussion Compared to the usual outpatient treatment, BPT was more
effective in the treatment of idiopathic headache, both at the clinical
and psychopathological level.
Conclusions The relation between headache and psychopathology is
controversial; yet the present study provides some evidence of the
effectiveness of brief individual or family psychodynamic therapy in
the treatment of idiopathic headache in childhood and adolescence.
Indeed, a better mental elaboration of intrapsychic conflicts may have
a protective role in the development of psychosomatic diseases.
HEADACHE IN CHILDHOOD AND ADOLESCENCE III
THE PREVALENCE OF PRE- AND PERINATAL COMPLICA-
TIONS IN CHILDREN WITH HEADACHE: A STUDY OF 200
PATIENTS AND THEIR MOTHERS
F. Galli, L. Canzano, V. Guidetti
Department of Child and Adolescent Neurology, Psychiatry and
Rehabilitation, University La Sapienza, Rome, Italy; e-mail: federi-
ca.g@uniroma1.it
Introduction Genetic and environmental factors are hypothesized to be
involved in the pathogenesis of migraine to a similar degree. Twin data
showed that the genetic liability to migraine is about 40%–60%, and the
contribution of non-shared environmental factors ranges from 35% to 55%
[1–4]. The study of environmental factors is compelling, as well as genet-
ic studies, in order to search for factors differentiating primary headache.
The aim of this study was to analyse the risk of migraine according to the
influence of complications during the pre/perinatal period. 
Patients and methods In a sample of 200 patients diagnosed with
headache and their mothers (ICHD-II criteria, 2004), we analysed
patients histories using a semistructured interview administered to the
mothers. Chi-square was computed to analyse contingency tables.
Results Sixty-four percent of the patients showed at least one pre/peri-
natal problem: 35.5% (71/200) reported prenatal problems and 28.5%
(57/200) perinatal problems. There was no difference between the
occurrence of migraine or tension-type headache in patients. Analysing
the headache subtypes of mothers, migraineurs had children with more
pre/perinatal problems (45.9%, 28/61), than mothers who did not suffer
from headache (23.3%, 17/73) (p<.05).
Discussion The explanation may be only speculative, but the occur-
rence of such a prevalence of pre/perinatal problems needs further stud-
ies, because of the likely implication in the pathogenesis of migraine
and non-migrainous headache. It is noteworthy that migrainous moth-
ers of migraine children showed a higher risk during pregnancy or
delivery: it may be speculated that migraine is a risk factor for preg-
nancy and delivery, whereas pregnancy is a protective factor for
migraine attacks in most women. Aromaa et al. (1996) [5] showed that
women with prepregnant headache had more pregnancy symptoms, as
well as poor emotional health and higher stress scores than controls. It
is noteworthy that migrainous mothers of migraine children showed the
highest risk during pregnancy and delivery. 
Conclusions Headache patients show a very high prevalence of
pre/perinatal problems compared to data from the general population
(10%–15%) [6]. Moreover, migraine in mothers is a risk factor both for
developing migraine in children and the occurrence of pre/perinatal
complications. The data has important aetiological and pathophysio-
logical implications.
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RECURRENT ABDOMINAL PAIN AND HEADACHE ARE
RELATED TO INTERNALISING DISORDERS: A CON-
TROLLED STUDY BY CBCL
1F. Galli, 1G. D’Antuono, 1S. Tarantino, 1F. Viviano, 2O. Borrelli, 
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Introduction Recurrent abdominal pain (RAP) and headache are among
the most common reason for paediatric consultation. Both disorders
affect daily life and activities: school absence, eating and sleeping prob-
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lems, incapacity to meet friends, and interruption of sports. Few studies
have been realized comparing the two disorders, even though similari-
ties characterize these disorders since the youngest age: recurrent,
paroximal, painful symptoms, and high familial recurrence, with com-
parable psychological pattern (mainly anxiety disorders). Headache and
RAP sufferers show anxiety (e.g. generalized anxiety, school and social
phobia) and mood disorders [1, 2]. However, very few studies on com-
mon psychological characteristics have been realised. 
Patients and methods We compared the occurrence of Internalising
and Externalising Disorders in headache, RAP and control group with
the meaning of Children Behavior Checklist (CBCL) [3]. The CBCL
was administrated to the accompanying parent of 25 headache patients,
25 RAP and 25 control subjects (range age 4–17.9). The headache
patients (12 migraine without aura, 5 migraine with aura, 5 episodic ten-
sion-type headache, 3 chronic tension-type headache) were recruited at
the Child and Adolescent Headache Centre of the University La
Sapienza. Headache diagnosis were made according to IHS criteria
(ICHD-II, 2004). Children with RAP (without organic cause) (n=25)
were recruited from the Department of Paediatric Gastroenterology of
the University La Sapienza. RAP diagnosis respected Apley and Naish’s
criteria [4]. The control group matched sample was recruited in different
schools. For statistic analysis, Mann-Whitney test was used. 
Results Forty-eight percent of headache children and 64% of children
with RAP showed statistically significant scores for Internalising Scale
compared to the control group (only 4%) (p<0.0001). None of the scores
for Externalising Scale Disorders was significant in all the three groups.
No difference according to gender and age of patients was found.
Discussion The headache and RAP groups showed a very similar trend
in the association with Internalising Disorders (anxiety and mood dis-
orders), outlining the role of psychological factors. Headache and RAP
patients showed a similar psychopathological liability (anxiety/mood
disorders), related to somatization disorders.
Conclusions From the youngest age, with the assessment and inter-
vention on psychopathology it is critical to manage headache and RAP
and prevent somatization.
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PET THERAPY AS BEHAVIOURAL TREATMENT IN CHILD-
HOOD MIGRAINE
D. Moscato, M.I. Peracchi, M. Mecaroni, V. Brizi
Childhood Headache Centre, San Carlo IDI, Rome, Italy; e-mail:
d.moscato@idi.it
Introduction Pet Therapy (PT) was born accidentally for the treatment
of autism [1]. Studies have ascertained that this therapy positively
modifies several physical parameters (AP, ECG, EEG, etc.). In PT, the
animal, with the help of expert personnel, acts as an emotional media-
tor in thus helping the patient to overcome several psychic, psycho-
social, and also psychomotor problems. In the genesis of headache,
both psychiatric comorbidities and social discomfort have considerable
weight. In the past, we published data, that indicated the positive effect
of this therapy for young headache sufferers [2, 3].
Patients and methods Forty-eight young patients (YP) were included
in the study (25 F; 23 M; 41 MO, 7 MA, range 6/16 years), in whom the
triggering cause was mainly linked to psycho-social discomfort (in the
family, at school or in the peer group) and who had high levels of anx-
iety and/or depression. The therapeutic scheme consisted of 15 weekly
sessions lasting 1 hour each. PT takes place in a 1000 sq.m. garden with
trees, animals (dogs, cats, rabbits, birds, sheep),  psychotherapists and 3
groups of YP aged 5–8, 9–11 and 12–17. The data controlled at T0 and
T30 weeks for headache: duration and frequency with Migraine Index
(M.I.); for the psychological aspect: drawing of the family, CDI,
Culture-Free Self-Esteem Inventory (CFSI), FAB-C, ability to deal with
a situation of discomfort, and semistructured questionnaire for parents.
Results Headache showed a >40% reduction (M.I. 13.3+/-8, 6.8+/-3.3;
p<0.005). The psychological characteristics greatly changed both in
the values of the tests CDI (13.3+/-3.6, 9.6+/-3.1; p<0.003), CFSI
(24.5+/6.2, 28.7+/-5.9, p<0.05), FAB-C (12.4+/-2.9, 10.5+/-2.9,
p<0.05), but above all, in how situations of discomfort were dealt with. 
Conclusions Undoubtedly, how pet therapy works is complex, since
three factors must be evaluated: the relationship with the animal world,
the psychotherapists, and finally, the therapeutic group. We think that
PT works as a result of taking care of the animal, through which the
child learns to abide by rules, socializes in handling animals, and
acquires greater confidence. Thus, we believe that this intervention
may be very useful in childhood migraine.
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QUALITY OF LIFE AND HEADACHE EVOLUTION IN A
CHILD AND ADOLESCENT COHORT
D. Brovia, S. Cesi, M.M. Cainazzo, L.A. Pini
Headache Study Centre, University of Modena and Reggio Emilia,
Modena, Italy; e-mail: pinila@unimore.it
Introduction This study examined the changes in the clinical picture
during the different phases of childhood with regard to the quality of
life, headache treatment and diagnoses following the ICHD-II criteria.
Subjects and methods The study included 67 subjects with age rang-
ing between 7 and 13 years visited at the Modena Headache Centre
between January 2002 and December 2003. The diagnosis according to
IHS criteria (ICHD-II) were migraine with (MA) and/or without aura
(MO), chronic and episodic tension-type headache. All diagnoses were
re-evaluated following the ICHD-II criteria. The present data are
referred to one third of the group (21 cases). The quality of life was cal-
culated by using the Ped-MIDAS questionnaire and the Child
Depression Inventory (CDI). We checked headache frequency, intensi-
ty, drug use and the presence of other treatment at the control visit.
Results At the moment, all the first diagnoses were confirmed after
one-year (12±6 months) follow-up (9.5% MA, 57% MO, 28% episod-
ic tension-type headache (ETTH), 5.5% chronic tension-type headache
(CTTH)). The clinical evolution was favourable in all patients and the
mean number of days with headache was 2/30; the intensity of pain
was unchanged. Eighty percent of examined subjects showed a Ped-
MIDAS score <10, which means no or mild disability, and only 20%
reached a moderate score of disability (>40). The CDI scores ranged
from 0 to 15, which is considered within the normal range (0–19). In 4
items there were more “pathologic responses” than normal responses:
item 2 “desperation”, 60%; item 14 “negative body image”, 52%; item
24 “self devaluation”, 70%; and item 26 “disobey”, 53%. Only one half
of patients underwent prophylactic treatment lasting two months, (30%
with calcium antagonists and 70% with tryptophan compounds). The
drug most used for the treatment of attacks was paracetamol (60%) and
only 2 patients used ketoprofen or sumatriptan spray. None underwent
psychological treatments in this first series.
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Discussion Data revealed the constancy of the diagnoses, which could
be related to the short follow-up period we examined, and the clinical
improvement of these subjects, even if only 20% of the subjects under-
went a real prophylactic short-term treatment. The CDI test showed
that patients had a bad perception of themselves with low self-esteem
and often feelings of desperation. These emotional states were con-
nected to disobedience and a negative body perception, which were
confirmed by clinical experience.
Conclusions The data are only preliminary and do not allow correct
statistical analysis which was avoided, but we plan to complete the
examination of all cohorts within two months.
THERAPEUTICAL CHOICES: THE STATE OF THE ART
AND FUTURE DEVELOPMENTS
A SIX MONTH OPEN-LABEL STUDY TO TEST EFFICACY
AND TOLERABILITY OF LEVETIRACETAM AS PROPHYLAC-
TIC TREATMENT OF MIGRAINE WITH AURA
F. Brighina, A. Palermo, A. Aloisio, M. Francolini, O. Daniele, B.
Fierro
Department of Neurology, Ophthalmology, Otorhinolaryngology and
Psychiatry, University of Palermo, Palermo, Italy; e-mail:
filippo.brighina@virgilio.it
Introduction Migraine with aura with high frequency of attacks could
represent a very demanding therapeutic problem. D’Andrea et al. [1]
reported efficacy of the antiepileptic drug lamotrigine in this form of
migraine. Levetiracetam is a new antiepileptic drug with an excellent
tolerability profile. Mechanisms of action of this drug remain largely
unknown, but recently, levetiracetam has been shown to exert inhibito-
ry effects on N-type calcium channels. The aim of this study was to
evaluate the efficacy of levetiracetam as prophylactic treatment for
migraine with aura with high frequency of attacks.
Methods We performed a small open-label trial treating 16 patients
affected by migraine with aura with high frequency of attacks. After a
1-month run-in period, patients were treated with levetiracetam at the
dosage of 1000 mg/day for 6 months.
Results Attack number per month was significantly reduced during the
first month (vs. run-in: p< 0.001), and it further lowered during the sec-
ond month (2nd vs. 1st month: p<0.001) and the third month (3rd vs.
2nd month: p<0.001) of the treatment. This improvement persisted
unchanged during the remaining three months of treament. In 7 of 16
patients (44%), the attacks were completely abolished after 3 months
of treatment. Severity and duration of headache and duration of aura
were also significantly reduced at the 3rd and 6th months (p<0.001).
Levetiracetam was well tolerated (only 3 patients complained of light
dizziness and somnolence).
Conclusions Levetiracetam was proven effective and safe in the treat-
ment of migraine with aura. Controlled trials are needed to confirm the
observed results. 
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ACUPUNCTURE EFFICACY IN THE PREVENTIVE THERAPY
OF MIGRAINE PATIENTS WITH OCCIPITAL PAIN LOCAL-
IZATION: PRELIMINARY RESULTS OF A PILOT STUDY
1G. Bruti, 1C. Mostardini, 1V. Villani, 1F. Di Stani, 2A. Liguori, 2F. Petti,
2L. Guardia, 2N.V. Viet, 2C. Panico, 2M. Cannizzaro, 1R. Cerbo
1Headache Section of “Enzo Borzomati” Pain Centre, Policlinico
Umberto I, Department of Neurological Sciences, University La
Sapienza, Rome, Italy; 2Paracelso Institute, Rome, Italy; e-mail: gian-
luca.bruti@uniroma1.it
Background The potential role of acupuncture for the treatment of
chronic neck pain as well as for the prevention of migraine has been
demonstrated. Recently, it has been suggested that the trigeminocervi-
cal complex plays a crucial role in the pathophysiology of neck dis-
comfort which accompanies the migraine attack.  The aim of this study
was to evaluate the efficacy of acupuncture treatment in the prevention
of migraine with occipital pain localization. 
Patients and methods A sample of migraine patients suffering from
“back” pain was consecutively recruited according to ICHD-II criteria
(2004). All patients underwent neurological examination, tenderness
examination of craniomandibular muscles and physical examination of
the cervical spine. The Beck Depression Inventory (BDI) and the State
and Trait Anxiety Inventory (STAI 1-2) were also administered to each
patient. To evaluate migraine disability, Headache Impact Test 6 items
(HIT-6) and Migraine Disability assessment (MIDAS) were adminis-
tered. The acupuncture treatment consisted of a combination of body
acupuncture and ear acupressure. Point selections was carried out,
according to the literature, considering each acupoint to have a positive
effect on chronic pain in the neck regions. Each subject received two
treatments per week and a total of 16 treatments over an 8-week period.
Preliminary results Of the 26 patients recruited (mean age±SD =
42±10 years; 24 females and 2 males), 24 patients had completed the
study (mean age±SD = 44±8 years), and 2 female patients dropped out.
After the acupuncture treatment period, we observed a significant
reduction of the scores in the clinical and psychometric variables in all
migraine patients (p<0.05). 
Conclusions Our data confirm that adequate acupuncture treatment
may reduce the frequency and intensity of pain as well as migraine
disability also in patients with severe and refractory migraine. The
therapeutic efficacy of acupuncture in migraine treatment has been
observed also in the reduction of depressive and anxiety states. We
hypothesized that an accurate and multidisciplinary evaluation of
migraine patients performed by both the acupuncturist and neurologist
may be important to specifically select the acupoints in a heteroge-
neous pathology such as migraine. It may be important to pick out
these clinical features in migraine, not only for the therapeutic impli-
cations but also for understanding the pathophysiological link
between cervical spine and pain features of migraine attack as well as
for understanding the therapeutic “mechanisms of action” of acupunc-
ture in migraine prophylaxis.
AN EXPERIENCE OF HATA YOGA AS A SIDE THERAPY FOR
HEADACHE SUFFERERS
M. Galli, M. Paganelli, L.A. Pini
Lega Italiana Cefalalgici – Onlus, Modena, Italy; e-mail: pinila@uni-
more.it
Introduction Since chronic headache often produces generalized pain
and is often accompanied by depression and/or anxiety, we thought that
self-help groups could be of therapeutic benefit.
Patients and methods Twenty-five patients suffering from chronic
daily headaches (80% with analgesic overuse, as stated by the ICHD-
II classification), 15 women and 7 men aged 35–63 years (mean age
52) participated freely in this study. A trained Yoga master led the
group in Hata Yoga and a questionnaire was used to evaluate the results
of this approach. Each session lasted one and one-half hours once a
week in the period November 2004–March 2005. 
Results Although patients were often in pain, worked and had a fami-
ly to take care of, the attendance was always quite high. From the ques-
tionnaire, 90% of participants reported that they had learned to relax,
by reaching an inner calm, and freeing their minds when “the whole
body was wreathing with pain”. Their opinion regarding this experi-
ence was excellent and 80% referred a significant improvement in their
quality of life.
Conclusions The patients discovered that they needed to learn to listen to
their body and breathing despite the frantic type of life they led. They also
discovered the pleasure and the importance of taking care of themselves
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as a whole rather than following a purely rational, drug-based approach to
their disorder. Also, being together with other people who understood
each other when they tried to explain their pain proved extremely encour-
aging and reassuring. The caring and sharing has been a highly helpful
aspect of the yoga activities. 
*This experience was supported by grants from Lega Italiana Cefalalgici
(LIC) and the Municipality of Modena.
HYPNIC HEADACHE: TREATMENT AND REPORT OF FOUR
CASES
A. Romorini, G.M. Patruno, G. Alberti
Neurology Unit, Magenta Hospital, Milan, Italy; e-mail:
alessandro.romorini@ao-legnano.it
Hypnic headache (HH) is a rare syndrome first described by Raskin in
1988 [1]. Until 2003, over 70 cases had been reported in the literature
[2]. The pathophysiology of hypnic headache is unknown, but the
hypothesis of a chronobiological disturbance is also supported by the
efficacy of lithium in disorders such as cluster headache [2]. The four
clinical cases consisted of two men aged 58 and 70 years, and two
women aged 79 and 71 years, who fulfilled the criteria of the
International Headache Society classification (ICHD-II) [3]. Magnetic
resonance imaging, electroencephalography and twenty-four hour
blood pressure monitoring were normal. Polysomnographic findings in
a male patient also demonstrated sleep apnoea syndrome. The prophy-
lactic treatment with caffeine and melatonin, administered together
before bedtime, reduced in over fifty percent of the patients the fre-
quency and intensity of headache. Some studies suggested that HH
may be a REM sleep disorder related to disturbances of the brainstem
[4], but the attacks can occur also in some patients during non-REM
sleep [5]. In older patients, the function of the hypothalamic-pineal
axis is reduced, thus impairing melatonin secretion. Lithium increased
melatonin levels. We suggest caffeine and melatonin as possible first
line prophylactic treatment in these patients.
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AUTOLOGOUS EPIDURAL BLOOD PATCH IN THE TREAT-
MENT OF HEADACHE CAUSED BY SPONTANEOUS CSF
LEAK
1E. Ferrante, 2R. Wetz, 2I. Arpino, 2A. Savino
1Neurosciences and 2Emergency Room Deparment, Niguarda Cà
Granda Hospital, Milan, Italy; e-mail: enricoferrante@libero.it 
Objective To evaluate the efficacy of epidural blood patch (EBP) in
the treatment of headache by spontaneous CSF leakage (SCSFL) [1].
Background Spontaneous intracranial hypotension (SIH) generally
results from spontaneous spinal CSF leakage. EBP has emerged as
the most important nonsurgical treatment for SCSFL. We have
attempted to determine the efficacy of EBP in the treatment of
headache by SCSFL.
Patients and methods We observed 24 patients with SCSFL between
1992 and 2004. In 6 patients (4 women and 2 men; age range 31–66
years, mean age 44) we performed EBP treatment. Follow-up ranged
from 6 months to 2 years. All patients had received EBP in the lumbar
region, using 15 to 30 ml (mean 23ml) of autologous blood.
Results All patients had orthostatic headache. Other manifestations
were nausea, vomiting, mild neck stiffness, tinnitus, blurred vision,
diplopia, and bilateral upper limb numbness. Spinal taps were per-
formed in 4 patients. The level of the leak was determined in 4 patients.
All 6 patients failed an initial conservative treatment, which consisted
of bed rest and hydration, (over a period of 2 to 13 months). The first
5 EBP patients (83%) became asymptomatic; one patient responded
only to a third EBP. In 3 patients the EBP was given at the lumbar level
where we found the leak, instead 1 patient with cervical CSF leak
received EBP at a different level from the leak. “Blind” lumbar EBP
was performed in 2 patients. All patients after injection remained in the
Trendelenburg position at approximately 30° for 24 hours. Headache
relief was obtained immediately.
Conclusions Our data confirm the efficacy of EBP and also suggest the
efficacy of “blind” lumbar EBP and especially the importance of a pro-
longed Trendelenburg position in SCSFL.
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HEADACHE BY SPONTANEOUS CERVICAL CSF LEAK
TREATED WITH LUMBAR EPIDURAL BLOOD PATCH
1E. Ferrante, 2I. Arpino, 1A. Citterio, 1E. Boccardi, 1P. Tiraboschi, 
2A. Savino
1Neurosciences and 2Emergency Room Department, Niguarda Cà
Granda Hospital, Milan, Italy; e-mail: enricoferrante@libero.it
Objective To evaluate the efficacy of lumbar epidural blood patch (EBP)
in the treatment of spontaneous cervical CSF leakage (SCCSFL) [1].
Background Spontaneous intracranial hypotension (SIH) generally
results from spontaneous spinal CSF leakage. Treatment is usually con-
servative, consisting of bed rest. Sometimes an autologous EBP at the
site of CSF leakage may be necessary. When CSF fistula occurs at the
level of the cervical spine, EBP is difficult to perform.
Design/methods We report one case of SCCSFL (among the 24 with
this condition evaluated between 1992 and the present).
Results A 31-year-old woman presented sudden, intense nucal pain,
lasting for about 10 s, followed by gravative occipito-nucal and frontal
orthostatic headache. Additional clinical symptoms included nausea,
vomiting, tinnitus and hearing impairment, mild neck stiffness, and
bilateral upper limb numbness. All symptoms worsened with the ortho-
static position. Neurological examination, routine blood tests, and brain
CT scan were normal. A brain MRI showed diffuse pachymeningeal
enhancement and mild subdural fluid collections. Angio-MRI was
unremarkable. After two months of bed rest, orthostatic headache and
tinnitus were still present. At this time, spinal MRI and MRI myelogra-
phy were negative, whereas CT myelography showed left-sided con-
trast extravasation (C2-C3 level). CSF pressure was not measurable.
The patient was treated with autologous EBP (20 ml) at the level of L1-
L2. After injection, she remained in the Trendelenburg position at
approximately 30° for 24 hours. She was asymptomatic within 24 hours
after EBP. At 6-month follow-up she was in good health. 
Discussion and conclusions In this case we hypothesize that recovery
is due to the fact that EBP, even though injected at the level of the lum-
bar spine (i.e., far from the site of CSF leakage), may move upward
reaching the cervical segments. This is possibly favoured by a pro-
longed Trendelenburg position. Alternatively, EBP may determine an
increase in intracranial pressure, which would favour the closure of the
everting borders of the dural hole. Thus, extradural injection of autol-
ogous blood at the level of the cervical spine, where the procedure is
difficult to attempt, may not be necessary.
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TREATMENT OF TENSION-TYPE HEADACHE
A. Forabosco, F. Vecci, T. Grandi, S. Superbi
University of Modena and Reggio Emilia, School of Dentistry,
Modena, Italy; e-mail: forabosco.andrea@unimo.it
Introduction The “tension-type headache” often represents the symp-
tomatologic manifestation of temporomandibular disorders. It is fre-
quently associated with an occlusal alteration able to produce a mus-
cular-articular overload [1].
Patients and methods Limitation of the functional mandible’s move-
ments, teeth abrasions, or hypertrophy of the mandibular elevator mus-
cles often represent the associated symptoms of myogenous pain
regarding “tension-type headache” [2]. The dentist’s aim should be to
diagnose and to treat adequately muscular problems originating from
the stomatognathic system. To obtain this goal, a Michigan splint treat-
ment was performed. It is a resin device applied on the maxillary den-
tal arch, and is realized by an irreversible hydrocolloid impression of
both dental arches of the patient and by a “construction wax-bite”,
which indicates the maxillary-mandibular relationship [3].
The wax-bite’s height was defined to obtain the most relaxed muscular
position, and the minimal, symmetric muscular activation was checked
by a clinical palpation examination at the established position. Fifty
patients (30 women and 20 men; aged between 18–60 years) were
selected for this study. Inclusive criteria were: (1) diagnosis of muscu-
lar disorders, and (2) alteration of occlusion or of mandibular move-
ments. Clinical parameters (maximal opening, degree of masticatory
muscle tension, degree of pain during mandibular movements), and
surface electromyography (sEMG) were recorded on days 0, 20, and
60. The electromyography test was performed using surface electrodes
placed on the skin corresponding to the maximum projection of the
muscle points. The skin was previously cleaned with ethyl alcohol to
remove any greasy residues. Electrical performance recordings were
obtained from both pairs of masseter, anterior temporalis, sternoclei-
domastoid, and anterior digastric muscles, both at rest and during func-
tion. Therapy should resolve problems of hyperactivity or disequilibri-
um between the different muscles and restore muscular balance [4]. All
the patients were instructed in proper dental hygienic, and the correct
use of the splint.
Results A remarkable reduction in the clinical parameters recorded at
each follow-up was observed in all patients. The sEMG recordings
showed a significant decrease in hyperactivity and a favourable mus-
cular balance was restored at each session.
Discussion and conclusions The “Michigan splint” seems to be an
efficient device to lessen or eliminate muscular tension related to the
“cranio-cervico-mandibular” disorders. “Michigan splint” therapy
should be part of a multidisciplinary treatment of tension-type
headache. 
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CHRONIC HEADACHE PREVENTION
SUPERFICIAL EMG IN CHRONIC TENSION-TYPE
HEADACHE: FOLLOW-UP
P. Tamburro, L. Di Ianni, G. Di Meo, G. Siconio, P. Serra
Department of Aging Medicine and Sciences, Headache Centre, ASL 2,
Chieti, Italy; e-mail: ldiianni@interfree.it
Our study, began in 2004, and continues to follow 10 patients (6
women and 4 men) with chronic tension-type headache (CTTH) and
temporomandibular joint disease. All patients underwent superficial
EMG of the jaw muscles and neurological examination. Patients were
divided into 3 groups for different treatments: Group 1 was treated with
BITE and muscle relaxants for 1 month; Group 2 with muscular
stretching, psychotherapy and muscle relaxants for 1 month; and
Group 3 with muscle relaxant for 2 months. Group 1 showed 70%
reduction of the symptomatology, Group 2 45% reduction of the symp-
tomatology, and Group 3 25% reduction of the symptomatology.
Conclusions Superficial EMG study of jaw muscles is very important
in CTTH with temporomandibular joint disease.
TREATMENT OF 20 CASES OF CHRONIC TENSION-TYPE
HEADACHE WITH ACUPUNCTURE
M. Calia, A. Caruso, G. Schimmenti, M. Rotolo, E. Scarpuzza
U.O.S. of Pain Therapy, Hospital “G.F. Ingrassia”, A.U.S.L. n. 6,
Palermo, Italy; e-mail: matteocalia@libero.it
Introduction Several studies on the treatment of chronic tension-type
headache (CTTH) with traditional Chinese acupuncture have been
published, but further studies need to be carried out to verify the valid-
ity. The peculiarity of this study was the use of International Headache
Society (IHS) diagnostic criteria in the recruitment of patients.
Patients and methods The study was conducted on a total of 20 patients
(mean age 32 years: 8 males and 12 women) fulfilling IHS criteria for
CTTH. Two parameters were considered: (1) number of days of
headache/month; (2) number of nonsteroidal anti-inflammatory drugs
(NSAIDs) taken (oral medication)/month. The patients were asked to
keep a daily diary for headache and oral NSAIDs one month before
treatment, during the treatment period and one month after the treatment
ended. The patients underwent a total of twelve sessions of 20 minutes
each. The first eight sessions were weekly, whereas the last four sessions
were bi-weekly. The treatment required a period of four months.
Results The diaries before and after treatment were compared: three of
the 20 patients achieved complete remission of symptomatology and no
longer took NSAIDs; four patients experienced a 70%–-80% reduction in
headache frequency and the number of times they used NSAIDs/month;
six patients had a 40%–60% reduction in headache attacks; four patients
had a 20%–30% reduction; and three patients had no changes.
Conclusions We believe that the treatment of CTTH should be dealt
with in a multidisciplinary manner in further studies, i.e., acupuncture,
as well as other different techniques (i.e., relaxation training, biofeed-
back, etc.), are reasonable alternatives to pharmacological therapy.
EFFECTS OF AMITRIPTYLINE AND INTRA-ORAL DEVICE
IN CHRONIC TENSION-TYPE HEADACHE: A CLINICAL AND
LASER-EVOKED POTENTIALS STUDY
1M. de Tommaso, 2E. Shevel, 1M. Guido, 3D. Di Venere, 1G. Libro,
1S. Genco, 1C. Monetti, 1L. Losito, 1M. Sardaro, 1P. Livrea
1Neurological and Psychiatric Sciences Department, University of
Bari, Bari, Italy; 2The Headache Clinic, Johannesburg, South Africa;
3Odontostomatologic and Surgical Department, University of Bari,
Italy; e-mail: m.detommaso@neuro.uniba.it
Introduction We reported that laser-evoked potentials (LEPs), record-
ed at the vertex, were increased in amplitude in chronic tension-type
headache (CTTH) patients when pericranial sites were stimulated; the
amplitude increase was significantly associated with the Total
Tenderness Score (TTS) [1]. These findings suggested that pericranial
tenderness may be a primary phenomenon that precedes headache and
is mediated by a greater cortical, pain-specific hypervigilance. In the
present study, we examined clinical and LEP features in two groups of
CTTH patients treated with two different approaches: application of an
intra-oral prosthesis, aimed at reducing muscular tenderness, and
administration of amitriptyline, acting at the central level.
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Patients and methods Eighteen patients suffering from CTTH
(ICDH-II, 2004), participated in the study. We performed baseline
evaluation of the clinical features and LEPs in all patients (T0) vs. 12
age- and sex- matched controls; subsequently, patients were randomly
assigned to a two-month treatment with amitriptyline or an intra-oral
prosthesis. All subjects underwent a recording session with 23 scalp
electrodes, placed according to the 10–20 International System. The
stimulus was a laser pulse generated by CO2 laser; the dorsum of the
hand and the cutaneous zones corresponding to pericranial muscles
were stimulated. Clinical and LEP evaluations were performed after
treatment (T1).
Results The late LEPs, especially the P2 component, were significant-
ly increased in amplitude in the CTTH group; the P2 amplitude was
correlated with TTS and anxiety levels. Both the intra-oral prosthesis
and amitriptyline significantly reduced headache frequency. TTS was
significantly different between the two groups; in fact, it was reduced
in the prosthesis-treated group. The amplitude of the P2 response elicit-
ed by stimulation of the pericranial zones showed reduction after
amitriptyline treatment.
Discussion and conclusions Overall, the results of this study support
pericranial tenderness as a primary phenomenon in chronic tension-
type headache: it may initiate a self-outstanding circuit, favoured by
central sensitization at the level of the spinal dorsal horn/trigeminal
nucleus and cortical nociceptive areas devoted to the attentive and
emotive components of pain. Interventions at both the peripheral and
central level may interrupt this reverberating circuit, improving
headache outcome.
Reference
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BOTULINUM TOXIN: A PLACEBO CONTROLLED TRIAL
P. Tamburro, L. Di Ianni, G. Di Meo
Department of Aging Medicine and Sciences, Headache Centre, ASL
2, Chieti, Italy; e-mail: ldiianni@interfree.it
Our study began in 2004, and continues to follow a group of 20
patients: 10 treated with Botulinum Toxin Type A (BTX-A) and 10
treated with sodium chloride 0.9%. Patients had previously tried
many prophylactic therapies (Ca-agonists, Beta-blockers,
antiepileptics) without having any significant improvement. The
treatments were based on injection of 25 units of BTX-A or 0.5 cc
of sodium chloride 0.9%: into the four frontalis sites; into the two
temporalis sites; into superficial sites; and into the glabellar sites.
The treatments were performed every 3 months for a year. After 12
months, 75% of patients treated with BTX-A showed a significant
reduction in the frequency and severity of migraine attacks. We
observed no reduction of the symptomatology in the patients treated
with sodium chloride. Practically all patients treated with BTX-A
continued the injections every 3 months and none of them had sec-
ondary effects either on muscles or in general. All the patients treat-
ed with sodium chloride 0.9% had no secondary effects but they did
not continue treatment.
Conclusions Therapy with botulinum toxin is increasingly used in the
prophylaxis of migraine with or without aura. Generally, it does not
have secondary effects.
CHRONIC DAILY HEADACHE AND MEDICATION OVERUSE:
COMPARISON BETWEEN IN- AND OUTPATIENT MANAGE-
MENT
C. Vollono, D. Ferraro, A. Capuano, D. Mei, G. Della Marca, G. Di
Trapani
Headache Centre, ”A. Gemelli” Hospital, Rome, Italy; e-mail:
lvol@libero.it
Introduction Chronic daily headache (CDH) is an invalidating pathol-
ogy affecting 4%–5% of the population. The majority of patients with
CDH also overuse acute medication. Medication overuse is thought to
play an important role in the transformation of episodic headache into
chronic headache. Furthermore, until the abused medication is with-
drawn, prophylactic medication may be ineffective in reducing the
headache frequency. 
Objective To compare the efficacy of a detoxification scheme in two
groups of patients: the first group was hospitalized for a ten-day peri-
od, while the second group was admitted to Day Hospital daily.
Patients and methods We studied two groups of 10 patients each,
affected by CDH with medication overuse, (>15 simple analgesics or
>10 triptans/combination medication intake per month for at least three
months) without psychiatric comorbidity or opioid/barbiturate overuse.
Patients underwent a 10-day treatment scheme consisting of: with-
drawal of the overused drugs and administration of dexamethasone
(4mg/day iv) and amitriptyline (75 mg/day). Subsequently, these drugs
were tapered and prophylactic treatment, chosen on the basis of the
patients’ characteristics, was began. Outcome measures were: number
of days with headache during treatment, headache index (number of
days with headache/total number of days) at 1 and 3 months and anal-
gesic intake in the 3 months following detoxification.
Results Headache index and analgesic intake were significantly lower
at follow-up as compared to the month before treatment. There was no
other significant difference regarding all evaluated parameters between
the two groups.
Conclusions Although the sample population is small, our results sug-
gest that an outpatient management of CDH with medication overuse
is a valid therapeutic option in the absence of conditions requiring hos-
pitalization (psychiatric or medical comorbidities, opioid/barbiturate
overuse, dehydration). Hospitalization, which represents a stressful
event for patients, can thus be avoided and management costs reduced.
ADVICE ALONE VERSUS STRUCTURED DETOXIFICATION
PROGRAMMES FOR MEDICATION OVERUSE HEADACHE
(MOH): A PROSPECTIVE, RANDOMIZED, OPEN-LABEL
TRIAL IN TRANSFORMED MIGRAINE PATIENTS WITH
REDUCED MEDICAL NEEDS
P. Rossi, C. Di Lorenzo, J. Faroni, F. Cesarino
Headache Clinic, INI Grottaferrata (Rome), Italy; e-mail:
paolo.rossi90@aliceposta.it
Introduction The effectiveness in MOH of doctor’s advice alone,
without adjunctive pharmacotherapy, has not yet been defined.
Aim To compare the effectiveness of intensive advice to withdraw the
overused medication with the effectiveness of two different structured
strategies for patient detoxification.
Patients and methods One hundred and eight patients diagnosed with
probable MOH plus migraine participated in the study. Exclusion cri-
teria were: previous detoxification experiences, co-existent, significant
and complicating medical indications, major depression, overuse of
opioids, benzodiazepines, and barbiturate-containing agents. The
patients were randomized in equal numbers into three different treat-
ment groups. Group A received only intensive advice to withdraw the
overused medication, group B underwent a standard outpatient detoxi-
fication programme, and group C underwent a standard in-patient with-
drawal programme. Withdrawal therapy was considered successful if,
after 2 months, the patient had reverted to an episodic pattern of
headache and was taking fewer than 10 doses of medication per month.
Results Three patients were excluded because they showed no
improvement following withdrawal. Sixteen patients dropped out of
the study (group A, n=5, group B, n=6, group C, n=5, p>0.05). Of the
89 subjects who completed the study, the success rates were: group A,
90%; group B 80%; and group C, 86.3% (p>0.05). In patients with
transformed migraine with reduced medical needs and no previous
detoxification experience, effective drug withdrawal may be obtained
through the giving of advice alone.
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APPLICATION OF THE ICHD-II DIAGNOSTIC CRITERIA FOR
PAEDIATRIC HEADACHE USING A COMPUTERIZED
STRUCTURED RECORD. PRELIMINARY RESULTS
G. Mazzotta, B. Gallai, F. Floridi, M. Allegretti, R. D’Angelo, F.
Barbanera, C. Olivito, B. Pinzo, R. Monni
Juvenile Neuropsychiatry Unit, University of Perugia, Perugia, Italy;
e-mail: mazzogio@unipg.it
The actual application, by a computerized structured record, of the
current International Headache Society (IHS) diagnostic criteria in
clinical practice has been investigated in adults while data in children
are lacking. We tested the computerized record, based on the ICHD-
II criteria, by entering and analyzing data reported on the case sheets
of 183 consecutive children (range 6–18 years) attending our paedi-
atric headache centre. The diagnoses reported by the clinician were:
migraine without aura (MO) in 108 patients; probable migraine with-
out aura (PMO) in 33; chronic migraine (CM) in 13; migraine with
aura (MA) in 4; episodic tension-type headache (ETTH) in 10;
chronic tension-type headache (CTTH) in 8; probable episodic ten-
sion type headache in 6; and non classifiable headache in 1.
Concordance between the clinical and the computerized diagnoses
was found in 131 of 183 cases examined (71.58%). There was
absolute agreement in the diagnosis (100%) in subjects with CM and
MA and almost complete agreement in those with MO (99.1%). In
the episodic tension-type headache group the concordance was
reached in 50% of the cases and only 9% was reached in the proba-
ble migraine group. In the remaining types of headache the comput-
erized record showed, other than the diagnosis provided by the clin-
ician, further probable alternatives. The computerized structured
record could be, in selected cases, an improvement for the specialist.
Further studies are needed to improve the software in order to
increase the diagnosis concordance.
